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ABSTRACT
The bacteriophage T4 regA protein translationally represses over 30 T4 early
genes, including the regA gene, by binding to the translation initiation region of the T4
mRNAs (Karam et al., 1981). Although the recognition sequence has been at least
partially characterized in a number regA sensitive mRNAs, there is no consensus
sequence or structural feature that is recognized by regA in all transcripts (Winter et al.,
1987; Webster et al., 1989; Unnithan et al., 1990). Recent studies have identified an
RNA binding site on regA protein, but there remains a large gap in our understanding of
how regA protein functions to temporally repress multiple mRNAs (Gordon et aI., 1999).
A genetic screen was developed to further identify regA protein:RNA interaction
sites. This approach uses a two-plasmid system in which lacZ expression is placed under
the translational control of T4 regA via the gene 44 recognition element (gene 44 RE)
(AAUGAGGAAAUU) on plasmid pLacZ-44RE. For regA expression the regA gene

was cloned into a pACYC derivative thereby placing expression of regA under the
control of a strong IPTO inducible promoter. The two plasmids were then transformed
into the E. coli strain WM1/F'. This approach allowed the rapid selection of regA
mutants with altered RNA binding affinity using a blue/white selection process. After
selection, the regA mutants were further characterized by sequencing of the mutant
genes, as well as by gel mobility shift assays with the mutant proteins and an RNA oligo
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of the gene 44 RE. Beta-galactosidase assays were also performed to quantify repression
levels obtained by IPTO induction of regA in cells transformed with the mutant regAs
In subsequent experiments, the gene 44 RE was mutated at two of the twelve
bases in order to vary regA affinity for the binding site and thereby vary regA repression
of the lacZ mRNA translation. In another experiment the Shine-Dalgamo sequence
upstream of the lacZ gene was weakened to reduce b-galactosidase expression.
Blue/white assays were performed to determine if these base mutations produced
variations in color due to variable expression of beta-galactosidase.
After comparing lacZ expression from plasmids with the various gene 44 RE
mutants, the regA gene was randomly mutagenized and the blue/white screen was used to
look for "gain of function" mutants. Potential mutants were expected to be altered in
their RNA binding specificity. The mutant colonies were sequenced to identify specific
mutations, in an effort to identify residues that are important in the recognition and
binding of RNA targets. The effects of individual mutations were further assayed by the
use of gel mobility shift and ~-galactosidase assays.
In other experiments color screening assays were performed to compare cells
expressing T4 regA with cells expressing the regA homologue found in bacteriophage
RB69. Previous studies had indicated that RB69 regA had a greater affinity for RNA
than did T4 regA, in vitro. The in vivo color assays were performed to determine if the
higher affinity in vitro translated into greater repression of lacZ in vivo.

Results from

these screens indicate that the hierarchy of repression of lacZ expression is from plasmids
with different gene 44 REs is different for T4 regA and RB69 regA proteins.

Xll1

The work described in Chapter II of this thesis is concerned with the aryl
hydrocarbon receptor protein (AHR). Recent studies have shown that the AHR protein is
rapidly degraded both in vivo and in vitro after exposure to agonist (Pollenz, R.S., 1996;
Giannone et a/., 1998; Giannone et a/., 1995; Pollenz et al., 1998; Roman et al., 1998;
Sommer et al., 1998). Additionally, it has been shown that the AHR contains putative
Nuclear Export Signal (NES) and Nuclear Localization Signal (NLS) sequences
(Davarinos and Pollenz, 1999; Ikuta et al., 1999; Pollenz and Barbour, 2000).
The purpose of the studies detailed in this thesis was to generate plasmids which
express AHR mutant proteins that contain mutant NES or NLS sequences but are
unimpaired in all other aspects of AHR functionality. These studies have shown that it is
possible to generate AHR proteins with mutations in the NES that dimerizes with ARNT,
binds DNA and supports ligand-mediated gene induction. These studies have also shown
that AHR proteins with mutant NLS sequences are also capable of dimerizing with
ARNT and binding to DNA. Additionally, these studies have indicated that the NLS
mutants were degraded more slowly after agonist exposure than wild type AHR
suggesting another level of regulation of the AHR pathway.

CHAPTER I
INTRODUCTION
A. Protein:RNA Interactions
Protein:RNA interactions are abundant and crucial for life. Whether beginning
with transcription of RNA by the protein RNA polymerase or ending with the ribosomal
translation of proteins from the RNA message, these two types of molecules are
inseparable. Not only are there protein:RNA interactions at the genesis of either type of
molecule, but for many RNA molecules, these interactions end only with their
degradation.

Between genesis and degradation of protein and RNA, protein:RNA

interactions are necessary for a variety of tasks which include mRNA capping, splicing,
polyadenylation, and tagging the mRNA for export to the cytoplasm (for review see Burd
and Dreyfuss, 1994). After export to the cytoplasm still other protein:RNA interactions
are necessary for the regulation of translation or for the protection of the RNA from
degradation until it has served its purpose. Finally, the eventual degradation of the
mRNA message is accomplished by still more protein ribonucleases.
To accomplish the varied tasks, which require protein:RNA interactions, proteins
have evolved a number of different RNA binding motifs (Burd and Dreyfuss, 1994).
Many of the motifs have, to a greater or lesser extent, been characterized, and some of the
better-known of these are: the RNP motif, the arginine-rich motif (ARM), the RGG box,
and the KH motif. Although these RNA binding motifs have been studied in great detail,
much work remains to be done. New RNA binding motifs such as the helix-loop-groove,
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found in the T4 RegA protein, are being discovered (Gordon et al., 2000). Hopefully,
characterization of these new motifs and others yet to be discovered will offer increased
insight into the many important cellular processes impacted by protein:RNA interactions.
B. T4 RegA protein
The bacteriophage T4 regA gene was discovered in the early 1970s when it was
observed that the T4 mutations, sp62 and R9, resulted in the overexpression of T 4 early
proteins (Wiberg et al., 1973; Karam and Bowles, 1974). These mutations were mapped
to a region between gene 43 and gene 62 and it was determined by in vitro coupled
transcription/translation assay that this region encoded a protein that repressed the
expression of T4 early genes (Winter et al., 1987).

This protein was T4 RegA a

translational repressor protein with a molecular weight of 14.6 kD and a pI of 9.6 (Adari
et al., 1985).

T4 RegA protein translationally represses over 30 T4 early genes, including the
regA gene itself, by binding to the translation initiation region (TIR) of the T4 mRNAs,

and blocking access of the 30S ribosomal subunit to the TIR (Karam et al., 1981). The
large number of genes translationally repressed by T4 RegA along with the observation
that the mRNA binding sites for RegA do not share a highly conserved consensus
sequence or have similar secondary structures make RegA unique among RNA binding
proteins discovered so far (Adari et al., 1986). Discovering the means by which RegA
accomplishes the hierarchical repression of its various targets has the potential for greatly
increasing our understanding of protein:RNA interactions.
The crystal structure of T 4 RegA protein revealed that the tertiary structure
consists of two domains, I and II, which together contain two f3-pleated sheets, 3 u-
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helices, and one tum of a 3/10 helix (Kang et al., 1995). Additionally, it was determined
that T4 RegA exhibits structural similarity to the snRNP UIA protein, and other RNA
Binding Domain (RBD)-containing proteins (Kang et al., 1995). However, mutagenesis
studies revealed that the RBD-like motif in RegA protein does not function in RNA
binding (Gordon et al., 1999).

To better define the region of RegA protein that

participates in RNA binding, molecular modeling has been used to identify exposed basic
and aromatic residues that could participate in RNA:protein interactions. Consequently,
a crevice and cleft region were discovered that were potential RNA binding regions
(Gordon et aI., 2000). Mutations have been introduced into cloned RegA protein within
the crevice and cleft regions as well as into exposed amino acid residues, and the effects
on RNA affinity have been measured by RNA gel shifts. This combined approach of
molecular modeling and site-directed mutagenesis has recently led to the identification of
the RNA binding site of the RegA protein and the discovery of a new RNA binding motif
(Gordon et al., 1999).
Although the identification of an RNA binding site is of primary importance in
understanding the role of T4 RegA, many additional questions are as yet unanswered.
The method by which RegA is able to temporally discriminate in the repression of its
various targets has yet to be completely understood. Additionally the role of amino acid
residues outside the primary binding site is as yet unclear. A primary focus of ongoing
research on T4 RegA is the development of new approaches and tools to aid in answering
these questions.

c. RB69 RegA protein
One of these new tools IS the homologue of T4 RegA found In the
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phylogenetically related bacteriophage RB69. Recent cloning and nucleotide sequencing
of RB69 Reg A protein showed that its predicted amino acid sequence is 78% identical to
that of T4 RegA protein (Joswik and Miller, 1992). However, gel mobility shift assays
have shown RB69 Reg A to have a 7-8 fold higher affinity for the T4 gene 44 recognition
element (gene 44 RE) RNA than does the T4 RegA protein itself (Sengupta et al., 2000).
This observation provides an opportunity for better understanding of structure-function
relationships in RegA protein. The identification of the region( s) or amino acid( s) of the
protein responsible for the difference in affinity for gene 44 RE may help explain a great
deal about the mechanics used by RegA to discriminate between its target sites.
D. Two-plasmid genetic screen
As a complementary approach to site-directed mutagenesis, a novel genetic
system developed by Jain and Belasco was applied to the RegA system. This approach
uses a two-plasmid assay system to screen for RegA mutants with altered RNA binding
specificity (Jain and Belasco, 1996). In the Jain and Belasco system the Rev protein
binding site on Rev genomic RNA, called the Rev Recognition Element (RRE), was
placed immediately upstream of the lacZ gene to create the plasmid placZ-IIB. In this
plasmid, the lacZ gene is under the control of a constituitively active promoter and
therefore does not require induction to produce (3-galactosidase protein. However, the
fusion of the RRE to lacZ potentially makes expression of lacZ subject to translational
repression by Rev. The plasmid placZ-liB also carries the gene for resistance to the
antibiotic ampicillin. In the second plasmid, pREV1, the Rev gene is inserted and placed
under control of the isopropyl-(3-D-thiogalactoside (IPTG)-inducible lac promoter to
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create pREVl. The pREVl plasmid also carries the chloramphenicol acetyl transferase
(CA T) gene for resistance to the antibiotic chloramphenicol.
The two plasmids placZ-IIB and pREVl were then co-transformed into E. coli
cells. After transformation with both plasmids the cells were plated on 5-bromo-4chloro-3-indolyl-~-D-galactoside

(X-Gal) and X-Gal plus IPTG. X-Gal is a colorless

substrate for the beta-galactosidase enzyme.

When X-Gal is cleaved by beta-

galactosidase the resulting product is blue. It was expected that cells containing the
expression vector placZ-IIB and grown on X-Gal plates, would be blue due to the
enzymatic activity of beta-galactosidase. Since the RRE is immediately upstream of the
lacZ gene in placZ-IIB, binding of Rev to the RRE should interfere with ribosome
binding to the lacZ mRNA and block translation of the lacZ message. It is expected that
colonies grown on the X -GallIPTG plates will be white since IPTG induction of Rev
synthesis should inhibit translation of lacZ. Beta-galactosidase assays of these cells
grown in liquid cultures were also performed to compare lacZ expression in the induced
and uninduced cells.
Since Rev protein represses lacZ expression by binding to the RRE and thereby
blocking the ribosome from binding to the Shine-Dalgamo sequence, point mutations
were made in the Rev Recognition Element in the placZ-lIB plasmid in order to reduce
the affinity of Rev for the RRE. These mutations were co-transformed into cells with the
wild type pREVl plasmid. The cells were then plated on X-gal and X-gaIlIPTG plates
and screened for loss of ability of Rev to repress beta-galactosidase expression. The
inability of Rev to repress some of the mutants indicated which individual bases were
most critical in Rev protein:RNA interactions.
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Next a mutagenic PCR technique was used to introduce random mutations into
the rev gene in hopes of creating a mutant or mutants that would regain the ability to
repress lacZ expression by binding to the defective RRE (Cadwell and Joyce, 1992).
This technique introduces a mutation for approximately every 1000 base pairs. The
resulting PCR products were ligated into cut pREY 1 vector to produce a library of
plasm ids containing mutated rev genes. WMI cells were then transformed with the
ligation mix and grown in culture overnight. DNA was extracted from the overnight
culture and stored as a mutant library for use in later experiments to screen for "gain of
function" mutants.
WMI cells were co-transformed with the placZ plasmids containing the mutated
RREs and the mutant rev library. The co-transformants were plated on X-Gal IIPTG
plates, and grown overnight. The resulting colonies were examined for color variances
and lighter blue or white colonies were selected as potential "gain of function" mutants.
The selected colonies were grown in culture overnight and plasmid DNA was extracted.
The resulting plasmids were sequenced and examined for mutations. A number of "gain
of function" mutants were identified with this screen. From the location of the mutations
within the protein, Jain and Belasco were also able to identify the residues most
important for Rev binding to its RNA target and thereby determine the probable RNA
binding site of Rev protein.

II. SPECIFIC AIMS
Although recent developments have given considerable information about the
function of RegA protein, much is still unknown. The ability of RegA to temporally
repress a large number of genes, which do not possess a consensus RNA target, is of
particular interest.

The work presented in this chapter was designed to provide

information about the function of T4 RegA protein in this area. In an effort to gain
insight into RegA's ability to recognize such a variety of RNA targets this project had the
following specific aims:
1. To determine if the 12 nucleotide T4 gene 44 recognition element sequence
confers sensitivity to T 4 RegA repression of the lacZ gene in vivo and, if so,
does RegA protein exhibit the ability to distinguish between wild type, G-7,
and G-9 variants of the gene 44 RE in vivo.
2. To identify mutants ofT4 RegA with altered RNA binding specificity.
3. To determine if the T4 gene 44 RE confers sensitivity to expression by RB69
RegA of lacZ in vivo.

III.

MA TERIALS AND METHODS

Bacteria:
Escherichia coli (E. coli) WMI/F': This cell line carries the lacZ gene. It also carries the
recA56 arg-, lac-proXIII nat, rifIF', and lactI genes.

Epicurian Coli® XLI-Blue (Stratagene): Supercompetent E. coli of strain recAI endAI
gyrA96 thi-I hsdRI7 supE44 relAI lac [F' proAB

lacfIZ~MI5

TnlO (Te{)].

Plasmids:

pASI-regA: This plasmid (also called pKW8) is the pASl expression vector containing a
560 bp insert with the regA gene. The gene (366 bp) is part of a Bam HIISal I fragment.
RegA protein expression is inducible by nalidixic acid treatment.

pAS t -RB69 regA: The RB69 regA gene was cloned into the pAS} vector. Like pAS 1regA, RegA protein expression is induced by treatment with nalidixic acid.

pREVl: This plasmid is derived from pACYCI84. It codes for chloramphenicol (cam)
resistance. This plasmid carries the rev gene under transcriptional control of the lac
promoter.

pACYC-WTT4: This plasmid is derived from pREVl. The rev gene was excised from
pREVI and replaced with T4 regA.

pACYC-WTRB: This plasmid is derived from pACYC-WTT4. The T4 regA gene was
excised from pACYC-WTT4 and replaced with RB69 regA.

pJacZ-IIB: This plasmid is derived from pREVI. The rev gene was excised from
pREVI and replaced with T4 regA.
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placZ-44RE: This plasmid is derived from placZ-IIB. The translation initiation region
was excised from placZ-IIB and replaced with theT4 gene 44 RE.

placZ-RE2: This plasmid is derived from placZ-44RE. The stem-loop immediately
upstream of the T4 gene 44 RE was disrupted by site-directed mutagenesis.

placZ-G-6: This plasmid is derived from placZ-RE2. The guanine at the sixth base
upstream of the adenine of the start codon was mutated to thymine.

placZ-G-7: This plasmid is derived from placZ-RE2. The guanine at the seventh base
upstream of the adenine of the start codon was mutated to thymine.

placZ-G-9: This plasmid is derived from placZ-RE2. The guanine at the ninth base
upstream of the adenine of the start codon was mutated to cytosine.

Buffers
lOX T4 polynucleotide kinase reaction buffer (USB): 0.5 M Tris-HCI, pH 7.6, 100
mM MgCI2, 100 mM 2-mercaptoethanol

lOX mutagenesis buffer (Stratagene): 100 mM Tris-acetate, pH 7.5, 100 mM
magnesium acetate, 500 mM potassium acetate (KC 2H 30 2), pH 7.5

lOX reaction buffer (Stratagene): 100 mM KCl, 60 mM (NH4)2S04, 200 mM Tris-HCl,
pH 8, 20 mM MgCI2, 1% Triton® X-lOa, 100 mg/ml nuclease-free bovine serum albumin
(BSA)

PI resuspension buffer (QIAGEN): 100 f..lg/m1 RNase A, 50 mM Tris-HCI, 10 mM
EDTA, pH 8

P2 lysis buffer (QIAGEN): 200 mM NaOH, 1% SDS
P3 neutralization buffer (QIAGEN): 3 M potassium acetate (KC2H302), pH 5.5
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QBT equilibration buffer (QIAGEN): 750 mM NaCI, 50 mM MOPS, pH 7, 150/0
isopropanol, 0.15% Triton® X-I 00

QC wash buffer (QIAGEN): 1 M NaCI, 50 mM MOPS, pH 7, 150/0 isopropanol
QF elution buffer (QIAGEN): 1.25 M NaCI, 50 mM Tris-HCI, pH 8.5, 15%
isopropanol

EB buffer (QIAGEN): 10 mM Tris-HCI, pH 8.5
Freeze/thaw buffer: 20 mM Tris-HCI, pH 7.5, 100 mM NaCI, 1 mM EDTA, pH 8
Start Buffer (pH 7.4 - 7.6) (Pharmacia Biotech): 20 mM phosphate, 0.5 M NaCI, 10
mM Imidazole
20X SSC (pH 7): 3 M NaCI, 0.3 M sodium citrate

Media
LB: 0.17 M NaCI, 1% tryptone, 0.5% yeast extract, pH to 7 with 5 N NaOH
LB agar plates: 0.17 M NaCI, 1% tryptone, 0.5% yeast extract, pH to 7 with 5 N NaOH,
200/0 agar (F or antibiotic selection add appropriate antibiotic)

IPTG:

isopropyl-~-D-thiogalactoside;

X-GAL: on
ONPG:

Fisher

5-bromo-4-chloro-3-indolyl-~-D-galactoside;

o-nitrophenyl-~-D-galactopyranoside;

Fisher

ACROS

Site-directed mutagenesis
All mutagenesis for this project was performed with this Stratagene
QwikChange™ kit.

Mutagenic primers (25-45 bases long) were designed as

complementary pairs so that a primer would anneal to each strand on the template. The
desired mutation was situated in the center of the primers. The primers were synthesized
by MUSC's Biotechnology Resource Laboratory.

The lyophilized primers were
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resuspended in 1 ml 20 mM Tris-HCI, pH 7.5. In thin-walled PCR tubes, IX reaction
buffer (10 mM KCI, 6 mM (NH4)2S04, 20 mM Tris-HCI, pH 8, 2 mM MgCh, 0.1 %
Triton® X-I00, 10 mg/ml nuclease-free BSA), 100 ng plasmid template, 125 ng
mutagenic primers, and 0.20 mM dNTPs were mixed and diluted to a final volume of 50
J..tl with distilled water.

To each mutagenesis reaction, 2.5 units (U) of Pfu DNA

polymerase was added for the amplification of the plasmid. The samples were then
placed in a thermocycler for the PCR. The cycling parameters were as follows:
95°C
1 cycle:
18-20 cycles: 95°C
58°C
72°C
72°C
1 cycle:
hold at 4°C

4 min. (to denature the plasmid template)
1 min.
1 min.
12-16 min.
7 min.

After mutagenesis, the parental plasm ids were digested for 1-2 hours at 37°C with
10 or 20 U of Dpn I restriction enzyme. Dpn I digests only methylated DNA. The
template DNA was extracted from E. coli cells and methylated by the cells natural
methylation enzymes. The mutagenized plasmids are PCR amplified copies of the
template and, therefore unmethylated and, unaffected by the Dpn I enzyme.

Transformation of calcium chloride-competent E. coli cells
25 ml LB was inoculated with 0.1 to 0.5 ml of E. coli cells. The culture was
grown to an optical density (OD) of 0.6 at 590 nm (ODS90). At this point, the culture was
incubated on ice for 30 minutes. The culture was centrifuged for 15 minutes at 6,000
rpm. The resulting pellet was resuspended in 10 ml of 100 mM CaCl 2 and incubated on
ice for 20 minutes. The cells were again spun down for 15 minutes at 6,000 rpm.
Finally, the pellet was resuspended in 2.5 ml 100 mM CaCho The cells were left on ice
for 0.5-3 hours or were refrigerated overnight. Using chilled pipet tips, 200 JlI of calcium
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competent E. coli cells were aliquoted into chilled 15 ml conical polypropylene tubes.
Volumes of mutagenized plasmid, measuring from 2 to 25 JlI, were added to the cells.
The tubes were gently agitated to mix the cells and DNA, then incubated on ice for 30
minutes. After this incubation, the cells were heat pulsed at 42°C for 45 seconds and put
on ice for 2 minutes. Exactly 0.8 ml of pre-warmed (42°C) LB was added to each tube.
The cells were grown for 1 hour at 37°C (shaking at 220-225 rpm). Aliquots of 100-300
JlI of transformed cells were spread on 2 LB/amp plates per transformation reaction. The
plates were incubated, upside-down, at 37°C overnight in an incubator. In the morning,
clones were picked and used to inoculate 3 ml of LB/amp. These small cultures were
allowed to grow for several hours at 37°C, then 0.1 ml of cells was used to inoculate 10 to
25 ml ofLB/amp. The cultures are grown at 37°C overnight.
Plasmid mini-prep (QIA GEN)

The cell pellets of overnight bacteria cultures were resuspended in PI buffer (1 ml
per 10 ml culture), to which 100 Jlg/ml RNase A was added, and transferred to sterile 1.5
ml sterile microcentrifuge tubes. The cells were then lysed with an equal volume of P2
buffer. Lysis was done for 5 minutes at room temperature after which the lysis buffer
was neutralized with P3 buffer (1 ml per 10 ml culture). The lysates were centrifuged,
and the supernatants were applied to anion exchange columns that had been equilibrated
with QBT buffer. The columns were washed four times with 1 ml of QC buffer. The
plasmids were eluted from the columns into sterile 1.5 ml microcentrifuge tubes with 0.8
ml QF buffer. The plasmids were precipitated with 0.7 volumes (0.56 ml) of isopropanol.
The samples were centrifuged for 15-30 minutes at 13,000 rpm in the cold. The DNA
pellets were dried on a Speed Vac (Savant) and resuspended in the appropriate volumes
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of IX TE.

The quality of the prep and yield of the DNA were evaluated by

electrophoresis on a 1% agarose gel in IX TAE buffer. The midi-prep and maxi-prep
protocols were essentially identical to the mini-prep, but scaled accordingly.
Alternatively Quick-spin mini-preps were used. These prep kits were also from Qiagen
and the suggested protocol was followed.

Inductions
Seed cultures of the cells to be induced were grown overnight at 37 DC. In the
morning, they were used to inoculate a desired volume of LB/amp. The cultures were
grown at 37°C until they reached an ODS90 of 0.8. One ml of each culture was saved in a
microcentrifuge tube for electrophoresis later. The remainders of the cultures were
induced with I mM IPTG and allowed to grow overnight at 37°C. The 1 ml aliquots of
cells were spun down, resuspended in 100

~IIX

TE buffer, and frozen. In the morning

the induced cultures were placed on ice, and I ml of the cultures was saved, spun down,
and resuspended in 100 JlI of 1X TE. U ninduced and induced cells were electrophoresed
on a polyacrylamide or polyacrylamide-SDS gel. The proteins were visualized by
Coomassie blue staining to compare RegA protein amounts in induced and uninduced
cells.

eeillysis - freeze/thaw
Induced cells were harvested by centrifugation. The pellets were quick-frozen in
a dry ice/ethanol bath for 2 minutes. The pellets were thawed in an ice water bath for 8
minutes. Freezing and thawing were repeated a minimum of 6 times. After the final
freeze/thaw, the pellets were resuspended in an appropriate volume of freeze/thaw buffer.
The cell suspensions were then incubated in an ice water bath for 30 minutes. The
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lysates were spun down, and the supernatants were taken off the pellets. The pellets were
resuspended in IX TE. Aliquots of the supernatant and the resuspended cell pellets were
electrophoresed on a polyacrylamide or polyacrylamide-SDS gel. The proteins were
visualized by Coomassie blue staining to compare RegA protein amounts in the
supernatant and in the pellet.

RNA gel mobility shift assays
Purified gene 44 RE 16mer RNA (5'-GAAUGAGGAAAUUAUG-3') was 5'end-labeled with T4 polynucleotide kinase and

y_32 p _ATP.

Increasing concentrations

(2.5 nM to 40 nM) of RegA were added to a constant concentration (10 nM) of gene 44.
Freshly thawed aliquots of induced cell supernatants were used for each experiment and
discarded. The reactions were carried out in a final volume of 10 III in 10 nM Tris-HCI,
pH 7.5, 10 nM NaCI, 1 mM EDTA, pH 8, and 1 mM DTT. The samples were incubated
on ice for 15 minutes then electrophoresed on a 60/0 polyacrylamide gel (NOVEX) in 0.5
X TBE (89 mM Tris, 89 mM boric acid, 4 mM EDTA, pH 8.3) at 4°C for 1 to 1.5 hours.
To eliminate the risk of RNase contamination, the electrophoresis apparatus was washed
thoroughly prior to each use. After electrophoresis, the gel was dried and placed on a
phosphor storage screen for 1-18 hours. Phosphor imaging on the STORM860 ™ was
used to quantitate the bound versus unbound 32P_gene 44 RE RNA in order to calculate
binding constants.
The apparent association constants (Kapps) were determined by a method similar
to that of Rebar and Paba (12). The Kapps were calculated by taking three or four points
on the titration curve. The mean of the binding constants was determined., and the Kapps
from 2-4 experiments were averaged. In each gel shift assay., wild-type RegA was used
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as a control. The formula used was: Kapp == [bound RNA]/[free protein] X [free RNA],
where [bound RNA] == [fraction

32 p _RNA

bound] X [total RNA]; [free RNA] == [total

RNA] - [bound RNA]; [free protein] == [total protein] - [bound RNA], assuming that one
protein per RNA was bound. The gel shifts assays were repeated two to four times, and
the Kapps were averaged in order to generate a final value.
Cloning the RB69 regA gene

The regA insert was amplified by PCR, using Tag DNA polymerase. The primers
were designed such that a Nde I site was introduced upstream of regA and an existing Sal
I site downstream of regA was amplified along with the regA gene.
Clones were visualized by colony hybridization. First, identical grids were
drawn on UV nitrocellulose filter paper and an LB/amp agar plate. The filter paper was
placed on another LB/amp agar plate. With a sterile pipette tip or toothpick, bacteria
colonies were picked from a plate of transformed cells and streaked on the identical grid
blocks on the nitrocellulose paper and the LB/amp agar plate. The plate with the grid
master plate and the plate with the filter paper were incubated overnight at 37°C. The
master plate was then refrigerated. The nitrocellulose membrane, however, was washed
(i.e. placed on a piece of chromatography paper saturated with the appropriate buffers)
for 3 minutes in 2% SDS, and 5 minutes each in 0.5 M NaOH/l.5 M NaCI, 1 M Tris/I.5
M NaCI, and 1 M Tris/l.5 M NaCl. The membrane was then placed (colony side up) on
dry chromatography paper to dry. The colonies were then UV cross-linked to the
nitrocellulose membrane. The filter paper was placed (colony side down) on a nylon
filter in a pan of 2X SSC. They were then rolled up tightly to avoid air bubbles and
placed into a hybridization tube. Hybridization fluid, pre-warmed to 60°C was added to

16
the tube. The tube was then placed in a rotary oven at 60°C for 30 minutes. 32P-Iabeled
peR primer was added to the tube and further incubated in the rotary oven for 2 hours.

The filter was then washed three times in 0.2X SSC/0.1 %SDS, pre-warmed to 60°C. The
filter paper was then dried on chromatography paper and placed on either X -ray film or a
phosphor storage screen. Clones that lit up were picked from the master plate. Plasmids
were purified from the cells and screened by a double restriction digest with BamH I and
Sal I to see if they released an appropriately sized insert. Potential positives were
sequenced to confirm they were pAS 1-RB69 regA clones.

Mutagenic peR: An error prone PCR technique was used to create the regA
mutant library. The PCR is performed using a reaction mix with a 10 fold excess of
cytosine and MnCh to encourage incorporation of mismatched base pairs into the PCR
product. A mutation for every 150-200 base pairs is generated.

Beta-Galactosidase assays: Cells to be assayed were grown overnight at 37°C.
After overnight growth the cells were diluted 1-33 in LB containing the appropriate
antibiotics and grown to an OD 600 of approximately 0.5. For the assay 0.5 ml of cell
culture was diluted with phosphate buffer. The diluted cells were then treated with 1
drop of 0.1 % SDS and 2 drops of chloroform, vortexed vigorously for 10 seconds, and
equilibrated in a water bath at 28°C for 5 minutes. Exactly 0.2 ml of ONPG was added
and the mixture was incubated until a faint yellow color appeared. Na2C03 was then
added and the OD of the solution was measured at OD420 and OD 550 . Beta-galactosidase
was then calculated in Miller Units.

IV. RESULTS

Site-directed mutagenesis and subsequent analysis of a large number of
mutant T4 RegA proteins have revealed the binding site of RegA protein for RNA
targets (Gordon et af., 1999). Additionally earlier experiments had shown that T4
RegA protein binding affinity was different for variants of the gene 44 RE in vitro.
(Webster and Spicer, 1990). However, although these experiments have given a
great deal of information concern amino acid residues which are important in the
binding site and binding affinity for RNA targets in vitro, much remains unclear
concerning the functional activities of T4 RegA. An in vivo comparison of
repression ability conferred by the differences in binding affinity had not been
done. Other experiments have shown that the phylogenetically related
bacteriophage RB69 demonstrates a 7-8 fold higher affinity in vitro for the T4
gene 44 recognition element (gene 44 RE) RNA than does the T4 RegA protein
itself (Sengupta et af., 2000). RB69 RegA proteins increased binding affinity in
vitro for the gene 44 RE also has not been examined for increase repression of

gene expression in vivo. Finally, although much information has been obtained
using site-directed mutagenesis, the process is both time consuming and
expensive. A faster and less costly approach to study T4 RegA protein would be
of tremendous in the further study ofT4 RegA protein.
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For the following studies the two-plasmid system, initially developed by
Jain and Belasco to study the Rev protein, was adapted to screen for T4 RegA
(Jain and Belasco, 1996). To adapt this system to the study of RegA, expression of
~-galactosidase

was placed under the control of RegA by fusion of the gene 44 RE in

front of the lacZ gene. RegA was expressed from a second plasmid under the control of
the

isopropyl-~-D-thiogalactoside

(IPTG)-inducible lac promoter. Cells containing both

plasmids were expected to synthesize

~-galactosidase

in the absence of regA expression

(i.e. in media lacking IPTG) and produce blue colonies. Identical cells were expected to

produce white colonies when regA is expressed (i.e. in media containing IPTG). After
construction of the gene44 RE-IacZ vector, mutations were introduced in the gene 44 RE
to reduce RegA protein's affinity for the gene 44 RE site. These gene 44 RE mutations
were based on the previously discussed in vitro analysis of RegA protein's affinity for
gene 44 RE variants, and were chosen with the expectation of blocking or reducing
RegA's ability to repress lacZ expression, thus, resulting in reduced

~-galactosidase

levels.
A. In vivo translational repression of a gene44-lacZ fusion gene by T4 RegA protein.
1. Construction and characterization ofpACYC-regA
The inducible expression plasmid containing the T 4 regA gene was created by
replacing the rev gene in pREYl with the T4 regA sequence. In addition to the rev gene,
this plasmid also contains the gene for chloramphenicol resistance (CAT) which allowed
for the selection of cells which were transformed with this vector. As a first step in the
cloning procedure, the rev gene was excised from pREY 1. As shown in Figure l, Cia I
and N de I restriction sites are located just downstream from the 5' end of the rev gene
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IREV
AATTGTGAGCGGATAACAATTT GAATTCATTAAAG AGGAGAAATTAACTATG AGAGGATCGATCCATATG

lac operator

Eco RI

S/[

Initiation
codon

CIa I

Nde I

Sail

pREV1
3600 bp

Ndel

+

I

IregA

AATTGTGAGCGGATAACAATTT GAATTCATTAAAG AGGAGAAATTAACTATG AGAGGATCGATCCATATG

lac operator

Eco RI

S/[

Initiation
codon

CIa I

Nde I

Sail

pACYC-regA
Nde I

3600 bp

Figure 1: Cloning of regA gene into pACYC expression vector: The plasmid pACYCregA was constructed by PCR amplification of the regA gene from pAS l-regA and
subsequent ligation into pREY 1. The PCR product and plasmid pREY 1 were both
restriction digested with N de I and Sal I to create sticky ends and to remove the rev gene
from pREVl. The cut plasmid and PCR product were then ligated with T4 liga.se and
transformed into CaCl2 competent WMI/F' cells.
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and a Sal I site is located just downstream of the 3' end of the rev sequence. Since CIa I
was the more 5' of the two sites with respect to the rev gene, a CIa I I Sal I digest was
initially chosen to excise the rev gene and linearize pREY 1.
Initial restriction digests of pREY 1 were performed with CIa I, Sal I, and CIa IISal
1. Sal I linearized the plasmid but CIa I did not cut. After further study it was found that
CIa I is sensitive to DNA methylation, and therefore was not a suitable enzyme for use in
this experiment. Accordingly the restriction digests were repeated using Nde I instead of
CIa 1. Nde I and Sal I linearized pREVl in both individual digests and in the double
digest. The use of the N de I restriction enzyme left 18 bases from the rev gene at the 5'
end of the new coding sequence when T4 regA was inserted into the plasmid. These 18
bases when transcribed and translated would result in a fusion protein of T4 RegA with
six additional N -terminal amino acid residues.
The T4 regA gene, to be cloned into the pREVl vector, was amplified from the
plasmid pAS l-regA by PCR. Complementary primers were used which contained an
Nde I restriction site to be added to the 5' end of the regA coding sequence and
encompassed a pre-existing Sal I site downstream of the 3' end of the regA gene. After
digestion with restriction enzymes N de I and Sal I, the resulting fragment was ligated
overnight into the pREVl vector from which the rev gene had been excised. WMI cells
were transformed with the ligation mix and plated on Luria Broth (LB) plates containing
chloramphenicol (cam) to select for cells which had received the ligated vector. The
plates were incubated overnight at 37°C and examined for colonies the following day.
The initial attempt at transformation failed to yield clones with the regA insert.
Analysis of the PCR product showed that they were not completely cut by the restriction
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enzymes. However, even with partial cutting some of the PCR product should have been
competent for ligation into the vector. Therefore, the ligation reaction was repeated a
second time, but again, no transformants containing regA were found. Based on this
information it was presumed that the concentration of regA insert was too low and most
of the transformants contained the original pREY 1 plasmid.
Therefore, to screen for a colony containing regA, a faster and more economical
method of identifying correct transformants was needed. Accordingly colony filter
hybridization was used as it is potentially a more efficient selection tool for finding low
frequency transformants containing the T4 regA gene in the presence of numerous
pREVl transformants. Accordingly, WMI cells were re-transformed with aliquots of a
regA-pREVl ligation mix and plated onto six LB/cam plates along with a control
transformation of wild type pREY 1 plasmid. After overnight growth, there were fifty to
eighty colonies per plate. These colonies were lifted onto nitrocellulose filter paper and
probed with a

32 p

labeled regA DNA fragment produced from the same type of PCR

reaction use to prepare the T4 regA insert for cloning. After hybridization overnight, the
filters were washed, dried and placed on a phosphor image screen for several hours. The
phosphor screen was then scanned and the developed image was printed onto a
transparency that was used as a template for locating potential transformant colonies on
the agar plates.
Approximately forty colonies were 'identified as potential candidates for
containing the regA gene. From these, twenty colonies were selected and grown in
culture overnight.

Plasmid DNA was extracted from each of these cultures and

restriction digests were performed to check for the release of a regA fragment. Aliquots
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of each digest were examined on a 1% agarose gel for the release of a N de IISal I
fragment. Digestion of one of the clones produced a fragment of just over four hundred
base pairs which was the expected size. This plasmid was sequenced and found to
contain the T4 regA gene. However, the regA gene contained a single nucleotide deletion
of a thymine in the second codon. Two of the other potential positive clones were
sequenced even though there was no fragment in the restriction digest. As expected,
these clones were negative for the regA gene.
Although the one positive clone was found to have a mutation, the hybridization
reaction yielded the first positive regA cloning results to this point. It was decided to
repeat the hybridization using a faster protocol that did not require overnight incubation.
This rapid hybridization method was designed to allow for a more accurate selection
process by making the probed colonies larger and more evenly spaced on the plates. In
this method WM 1 cells were transformed with the ligation mix and grown overnight as
before; however, the following day individual colonies were selected and streaked onto
duplicate plates containing one hundred numbered squares in a grid. On the first plate the
grid markings and streaks were on a nitrocellulose filter placed onto the agar. On the
duplicate plate the grid was marked on the bottom of the plate and the streaks were made
directly onto the agar.

The two plates were incubated at 37°C overnight.

The

hybridization reaction was performed on the colonies growing on the nitrocellulose filter
the following day.

This procedure required. the same amount of time as a normal

hybridization for the first filter or set of filters because of the second overnight growth
required. However, transformation plates can be stored in the refrigerator and additional
colonies from the sanle plates can be selected if additional hybridization reactions are
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necessary.
After the hybridization reaction the filter was dried and placed on X-ray film
overnight. The film was developed, and the hybridization filter was placed on a phosphor
image screen as in the previous screens. For this experiment, the screen was exposed for
six hours, and then scanned on a Molecular Dynamics phosphor imager.
This procedure was repeated twice with the ligation mix transformed into WM 1
cells. The second and third hybridization reactions yielded five and four potentially
positive clones respectively.

Each of these nine clones were selected and grown

overnight in a 15 ml culture, and plasmid DNA was extracted the following day. Three
of the nine clones contained the regA sequence, but each of the three contained
mutations. Two of the clones contained the same mutation of isoleucine 84 to threonine.
The third positive clone contained an adenine deletion in the fourteenth codon.
Although there had been some success in obtaining clones containing the regA
gene, the frequency of clones with mutations suggested that it was necessary to increase
the number of potential positive clones being found in order to obtain a wild type regA
clone. To increase transformation efficiency XL I-Blue supercompetent cells were used
in a new transformation with the pREVIlregA ligation mix. As expected, these cells
produced a much larger number of transform ants.
A fourth hybridization was performed which tested 300 (3 plates of 100) colonies
from the XL I-Blue transformation. Of the 300 colonies tested 46 were indicated as
potential positives for regA in situ hybridization assay. Ten of the positive clones were
picked for plasmid preps and sequencing. Four of the selected clones did not contain
regA. Two contained partial sequences, and two contained single base deletions: one
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contained a lysine 109 to glycine mutation, and one contained the complete and
unmutated regA sequence. The clone with the correct sequence was clone # 100 from
plate #3. This plasmid was initially labeled pACYC-regA-3-1 00, and, subsequently, the
name was shortened to pACYC-regA.
The above results indicated that there was a recurrent problem with mutations in

regA, which occurred either during the PCR reaction, which generated the DNA for
cloning, or in selection during the growth of the transformed cells. Since the majority of
clones contained mutations, it seemed likely that there was a selection against cells that
contained a complete and unmutated regA insert. Since high levels of RegA protein are
known to be toxic to cells, and since the lac promoter had been shown to allow a low
amount of expression even in uninduced cells (i.e. to allow leaky expression), it is likely
that the maj ority of WM 1 cells initially transformed with the regA gene were killed by
the toxic effects ofT4 RegA.
Because of these effects of RegA on cell viability, a different bacterial strain was
needed as a host for the vector expressing regA. WMI/F' cells, which contain the lac Iq
gene which encodes a super repressor of the lac promoter, were selected as a potentially
better host. The presence of lac Iq was expected to reduce "leaky" expression from the
lac promoter that occurs prior to induction with IPTG.

WMI/F' cells were transfonned with pACYC-regA vector DNA from the original
pACYC-regA-3-100 plasmid prep. After the transformants were plated and allowed to
grow overnight 3 colonies were selected and grown in culture for plasmid DNA
extraction. Culture #1 was also grown and induced with 1 mM IPTG at OD .85 and
allowed to grow overnight. Colonies #2 and 3 were selected and saved as back-ups
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should colony # 1 contain a mutation.
After growing overnight, the induced culture (3 -1 00 # 1) was centrifuged to pellet
the cells for analysis of regA expression. Samples of the uninduced and induced cells,
and the lysed pellet and supernatant were examined by SDS-PAGE. This analysis was
performed to confirm that the protein was induced and to examine the solubility of RegA
after the freeze-thaw lysis. SDS-PAGE analysis indicated that expression of the T4 regA
gene was strongly induced by IPTG, but the amount of RegA protein in the supernatant
seemed to be low in comparison with RegA induced from the plasmid pAS 1-regA, the
plasmid originally used to clone the regA gene.
To determine if the RegA protein produced by

pACYC-~egA

was functional,

RNA gel mobility shift assays were performed on cell supernatants. Clone pACYC-regA
3-100 # 1 cell supernatant was incubated with a

32 p

labeled 16 mer RNA oligonucleotide

corresponding to the T4 gene 44 recognition element and complexes were
electrophoresed on a native polyacrylamide gel (See Figure 2). The protein produced in
clone 3-100 appeared to be fully functional, as RNA mobility was retarded even with low
supernatant concentrations.
Plasmid DNA from clones #2 and #3 were sequenced to reconfirm the expressed
RegA protein was complete and without mutations. Sequence #2 was only a partial regA
sequence but #3 was found to contain the full and unmutated coding sequence for T4
regA. It seemed likely that the mutation in clone #2 occurred or was selected for during

the overnight growth in the WM1 cells used for the original plasmid prep (i.e., before
transfer into WM1/F' (lacfl) cells).

The presence of this mutation after only one

overnight growth in WM1 cells also served to confirm the necessity of using WMI/F'
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Figure 2: RNA Gel Mobility Shift Assay of T4 RegA Produced in pACYC-regA.
The supernatant produced by the freeze-thaw lysis of IPTG induced WM1/F' /pACYCregA-3-100 cells was incubated with a 32p labeled 16 mer RNA oligo containing the gene
44 RE and initiation codon. The band shifts indicate pACYC-regA codes for a functional
RegA protein.
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Figure 3: Schematic Diagrams of plasmids placZ-IIB and placZ-44RE: The
plasmid placZ-IIB was converted to placZ-44RE by QwikChange™ site-directed
mutagenesis. Eleven bases in the lacZ TIR were replaced with the gene 44 RE in one
mutagenesis reaction. Excised and inserted DNA sequences are shown in boxes.
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The QwikChange™ mutagenesis transformation produced approximately 300 colonies
per plate. One hundred of the colonies were streaked onto a nitrocellulose filter and a
duplicate LB/ampicillin (amp) plate for hybridization screening. A

32 p

labeled oligo

containing the gene 44 RE sequence, AATGAGGAAA TTA, was used as a hybridization
probe. Six of the colonies gave a positive signal. The six colonies were selected and
grown overnight for extraction of plasmid DNA. The plasmid DNA was then sequenced
and examined for the mutation and the proper lacZ sequence. One of the five sequencing
reactions failed but the other 5 sequences all contained the desired mutation. Three of
these sequences had additional mutations in the lacZ gene but the remaining two plasmid
sequences were correct. These two DNAs were saved and labeled placZ-44RE-76 and
placZ-44RE-65. PlacZ-44RE-76 was selected arbitrarily for use in this study and was
designated as placZ-44RE. WMl/F' /placZ-44RE cells were grown overnight on X-GAL
plates. The cells produced blue colonies confirming the presence of a functional lacZ
gene.
In order to carry out a successful screen for "gain of function" mutants it was necessary
to be able to easily distinguish, by color differences, between cells in which functional
RegA protein is induced and those in which it is uninduced or non-functional. To test
this ability, WMI/F' cells were transformed with the following combinations of
plasmids: placZ-IIB/pREVl, placZ-IIB/pACYC-regA, placZ-44RE/pREVl, and placZ44RE/pACYC-regA. After plating and overnight growth, individual transformants were
streaked onto LB/Amp/Cam plates containing X-Gal or X-Gal/IPTG. The appearance of
cells transformed with the various combinations of vectors is summarized in Table 1.
As shown in Table I, WMl/F' /placZ-44RE/pACYC-regA cells plated on the X-Gal/IPTG
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PLATES
PLASMIDS

X-GAL

X-GAL/IPTG

COLOR

GROWTH

COLOR

GROWTH

+
+
+
+

Blue

B/WMix

+
+
+
+
+

Blue

-

PlacZ-IIB

*****

White

PlacZ-44RE

*****

Blue

PlacZ-IIB

pREVl

Blue

PlacZ-IIB

pACYC-regA

Blue

PlacZ-44RE

pREVl

B/WMix

PlacZ-44RE

pACYC-regA

B/W Mix

+
+

Blue
White
Blue

Table 1: Color Comparison of WM1/F' Cells Containing Various Different Plasmid
Combinations on X-GAL and X-GAL/IPTG Plates. In cells transformed with the
parent plasmids placZ-IIB and pREVl, uninduced (X-GAL) cells are blue while induced
cells (X-GAL/IPTG) are white. In cells transformed with both placZ-44RE and pACYCregA, induction with IPTG inhibited cell growth. Growth and color were unaffected in
cells transformed with placZ-IIB/pACYC-regA or placZ-44RE.

31

plates gave a mixture of both blue and white colonies. The same cells plated on X-Gal
plates also produced a mix of blue and white colonies. However, the growth of the
colonies varied on X-Gal versus X-GaI/IPTG plates. The placZ-44RE/pACYC-regA
colonies, which were blue, remained blue while those that were white on the X -Gal plates
showed little or no growth on the X -GallIPTG plates. These results were unexpected, so
additional streak plates of individual isolates ofWMllF'/placZ-44RE/pACYC-regA were
made to further characterize the effects of RegA in IPTG-induced and -uninduced cells.
As before, the individual colonies streaked on the plates did not have homogeneous
appearance, but rather, were a mix of phenotypes that were eventually categorized into
three general groups: I) colonies that were blue on both the induced and uninduced plates,
II) colonies that were blue on uninduced plates and white on induced plates, and III)
colonies that were white on uninduced plates and had reduced or no growth on induced
plates. The plates in Figure 4 illustrate all three of the different types of colonies.
DNA sequence analysis of pACYC-regA plasmids extracted from Type I cells
revealed that most of the plasmids contained early truncations of the regA sequence or
deletions of the entire regA gene. DNA sequence analysis of pACYC-regA plasmids
extracted from Type II cells indicated the plasmids usually contained mutations in a
single codon of the regA gene or late truncations of the T4 sequence. Gel mobility shift
assays of the supernatants from freeze-thawed protein extracts of Type II cells produced
no detectable RNA shift, suggesting the extracts did not contain functional RegA protein.
However, these cells were blue when plated on X-Gal plates and white on X-Gal/IPTG
plates. This color change between induced and uninduced cells suggests that RegA was
active in repressing

~-galactosidase

expression.

However, since the gel shift was
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X-Gal Plate

X-Ga1fIPTG Plate

Figure 4: Effects of IPTG induction of RegA on lacZ expression. Both the color and
growth of bacteria are affected by regA expression in WMI/F IplacZ-44RE/pACYCregA. The streaks in grids 2, 6, and 8 are examples of Type I transfonnants that are blue
on both X-GAL and X-GAL/IPTG plates. The streaks in grids 1 and 5 are examples of
Type II transfonnants that are blue on X-GAL plates and white on X-GAL/IPTG plates.
The streaks in ·grids 3, 4, and 7 are examples of Type III transfonnants that are white on
X-GAL plates and are unable to grow when induced on X-GAL/IPTG plates.
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negative, the RNA affinity of RegA in these mutants must be significantly reduced. In
IPTG inductions of RegA in Type II cells, the RegA protein was highly over expressed.
Presumably it is this ability to be highly expressed without being toxic to the cells that
allows these low affinity mutants to repress lacZ expression. One example of a double
mutant was found in Type II cells. This mutant had Gly23Arg and Glu68Gly mutations.
In gel shift analysis of this mutant there was no detectable retardation of the RNA.
DNA sequences of pACYC-regA plasmids extracted from Type III cells usually
contained the unmutated and complete regA sequence, although a few plasmids from
white colonies were found that did not sequence. These latter cells most probably
contained a functional regA gene, but were modified in the sequence that is normally
complimentary to the sequencing primer. These cells were discarded as they were not
useful for this proj ect.
The continuing mutagenic tendencies of the regA gene even when transformed
into cells with the lac Iq genotype necessitated some modification to the protocol used to
screen for RegA mutants with altered binding specificities. Even though there was little
color change in induced or uninduced WMl/F' /placZ-44RE/pACYC-regA cells, a color
difference was found between WMl/F'/placZ-44RE/pACYC-regA cells and
WM I/F' /placZ-44RE cells lacking pACYC-regA even when both cell types are
uninduced. Presumably the color difference was a result of leaky expression of regA,
indicating that induction by IPTG may not be required to differentiate between cells
expressing RegA proteins with varying affinities for the gene 44 RE.

This color

difference suggests that it is possible to differentiate between cells containing a functional
T4 regA gene and those containing a non-functional gene, by plating them on plates
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containing only X-GAL and inspecting the colonies for variations in color development.
To determine if

~-galactosidase

levels of cells grown in liquid culture could be

correlated with the color variations observed in cells grown on X-GAL plates,

~

galactosidase levels were measured for WMI/F' cells transformed with the following
plasmids: placZ-IIB, placZ-IIB/pREVl, placZ-IIB/pACYC-regA, placZ-44RE, placZ44RE/pREVl, and placZ-44RE/pACYC-regA. These assays were repeated numerous
times and, although the actual repression ratios varied, it was possible to determine an
overall hierarchy of ~-galactosidase repression achieved by RegA and Rev proteins in
cells containing the various lacZ plasmids. PlacZ-Il/pREVI > placZ-44RE/pACYC-regA
> placZ-44RE/pREVI > placZ-IIB/pACYC-regA. These results confirmed that regA

does block the translation of the lacZ gene from placZ-44RE, and coupled with the color
differences between cells containing functional and non-functional RegA protein, noted
on X-Gal only plates, suggested that a rapid screen for "gain of function" mutants could
be developed.

b. placZ-RE2
Although the screen for "gain of function" mutants appeared to be possible based
on the data from experiments with placZ-44RE, the level of repression of lacZ by RegA
was not as high as expected. Since T4 RegA binds to single stranded RNA targets it
appeared possible that the stem-loop structure of the original Rev RE located
immediately upstream of the gene 44 RE could be hindering the binding of RegA.
Accordingly site-directed mutagenesis was used to modify the 5' untranslated region of
the RNA to disrupt the large stem-loop structure on placZ-44RE (Figure 5).
Three bases in the stem structure were mutated from AGG to CAT USIng the
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QwikChange™ protocol. This mutation was expected to eliminate the first stem of the
hairpin structure, producing a smaller stem-loop, which would be farther upstream from
the gene 44 RE, as shown in Figure 5. It was also hoped that the increased access of
RegA to the RE would increase the fraction of RegA protein in the cell that is bound to
the plasmid, and thereby, decrease the overall toxicity of RegA.
Following mutagenesis and transformation ofWM1/F' cells, six potential mutants
were selected and sequenced to determine if the mutagenesis reaction was successful. All
of the selected clones contained the mutated sequence. The altered plasmid was named
placZ-RE2.
To determine if a color difference could be observed between IPTG-induced and
uninduced WM1/F'/placZ-RE2/pACYC-regA cells, sixteen transformed colonies were
selected and streaked onto X-Gal and X-GaI/IPTG replica plates. After incubation at
37°C the colonies on the X-Gal plate were blue as expected, but there was little to no
growth on the X-Gal/IPTG plate. The inhibition of growth on the X-Gal/IPTG plates
suggest that the toxicity of RegA was not alleviated by the disruption of the stem-loop
structure in p lacZ-RE2
To compare the level of RegA repression of lacZ achieved when

~-galactosidase

is expressed from placZ-RE2 with repression observed from placZ-IIB and placZ-44RE,
~-galactosidase

assays were again performed with liquid cultures.

These results

demonstrated higher repression ratios (r) for cells transformed with placZ-RE2, (r=4-5)
than those measured for cells containing placZ-44RE (r= 1.5-2). However, these ratios
were still lower than that observed for placZ-lIB by Rev protein.

The results are

consistent with the hypothesis that RegA protein binding to the gene 44 RE was hindered
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Figure 5: Schematic diagram of plasmids placZ-44RE and placZ-RE2.
PlacZ-RE2 was made by site-directed mutagenesis of placZ-44RE to disrupt the
stem-loop structure of the RRE. This mutation was made to reduce the possibility of the
stem-loop structure interfering with the binding of T4 RegA to the gene 44 RE. Part of
the stem-loop remains intact but is moved further upstream from the gene 44 and should
not interfere with RegA binding.
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by the proximity of the stem-loop structure of the RRE. It was also determined that
unrepressed B-galactosidase levels in cells containing placZ-RE2 were 8 to 10 fold
higher than in cells containing placZ-44RE. This suggests that the stem loop structure in
placZ-44RE also interferes with the binding of ribosomes to the translation initiation
region of the gene 44 RE-IacZ fusion gene.
To determine what level of regA expression produces toxic effects in cells
containing placZ-RE2, the growth rates of cells induced with varying concentrations of
IPTG were measured. In these experiments cultures of WMl/F' /placZ-RE2/pACYCregA cells were grown to a density of 0.3 to 0.5 OD/ml and then IPTG was added. Two
separate experiments were performed in which a low range (5-20 mM) and a high range
(10-100 mM) of IPTG concentration were examined. WMl/F'/placZ-RE2 cells without
the pACYC-regA plasmid were also assayed at 100 JlM IPTG. As shown in Figure 6, the
growth of WM l/F' IplacZ-RE2 cells was dramatically reduced by the presence of the
pACYC-regA vector even in the absence of IPTG induction. It was also apparent that as
IPTG concentration increased, growth rate decreased. Thus, the growth rate of the cells
was inversely proportional to the IPTG concentration.

This confirmed that RegA

expression from the low copy pACYC-RegA vector is toxic to the cells, and suggests that
only low levels of regA expression should be used in screening for RegA mutants.
In order to determine if there was a level of RegA induction that was permissive
for cell growth on agar plates, which would allow detection of a color change between
colonies grown on X-Gal versus X-GallIPTG, streak plates were made on agar containing
varying concentrations of IPTG. Sixteen colonies of WMl/F' /placZ-RE2/pACYC-regA
were streaked on X-Gal plates containing 0, 10, 100, and 1000 JlM IPTG. The growth of
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Figure 6: Growth curve of IPTG induced cells: WMl/F' /placZ-RE2/pACYC-regA
cells were induced with progressively higher concentrations of IPTG. WMl/F'/pACYCRE2 cells were also grown in 100 J..lM IPTG as a control. Growth of cells was found to
be inversely proportional to IPTG concentration.
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all sixteen clones decreased as the IPTG concentration increased. However, there was no
corresponding color change between cells grown at the different IPTG levels. In an
attempt to avoid the problems of reduced cell growth in the presence of IPTG, the same
experiment was repeated on X-GAL plates containing IPTG concentrations of 0, 5, 10,
15, and 20 JlM. Cultures of WMI/pREVI/placZ-IIB, WMI/pACYC-regA/placZ-IIB,
WMI/pREVI/placZ-RE2, and WM1/pACYC-regA/placZ-44REwere streaked on these
plates. As shown in Figure 7 there was no color change in any of the cells as the IPTG
concentration increased from

°

to 20 mM IPTG. A possible explanation for the lack of a

color change on agar plates is that in

~-galactosidase

assays of cells grown in liquid

cultures, lacZ expression was found to be 8-10 fold higher in cells containing placZ-RE2
than in cells containing placZ-44RE. Because of this increase in expression, it is possible
that

~-galactosidase

levels remain high enough to produce blue colonies on X-gal/IPTG

plates even in the presence of IPTG induced RegA protein. This possibility suggests that
placZ-RE2 could potentially be used in a screen for super repressors, since an increase in
binding affinity could result in repression levels high enough to overcome the high levels
of lacZ expression from placZ-RE2 and produce white colonies on X-Gal plates.

c. placZ-G-6, placZ-G-7, and placZ-G-9
Previous studies of RegA protein binding to synthetic RNAs corresponding to the
gene 44 RE demonstrated that mutation of some bases in the gene 44 RE reduced RegA's
binding affinity for the gene 44 RE significantly, while other substitutions had little or no
effect, as shown the graph in Figure 8A (Webster and Spicer, 1990). In particular, the
single guanine to cytosine mutation at position G-9 (numbered with respect to the AUG
start codon) reduced RegA's affinity for gene 44 RE RNA to that of non-specific RNA
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Figure 7: Streak plates of WMl/F'/placZ-RE2/pACYC-regA cells with varying
IPTG concentrations. There was no significant color change in cells grown on X-GAL
plates as IPTG concentration increases. Grids 1-17 contain streaks ofWMl/pACYCregA/placZ-RE2 cells. Grids 18-21 contain streaks of WMl/pREVl/placZ-RE2 cells.
Grids 22-23 contain streaks of WMl/pREVl/placZ-IIB cells. Grids 24-25 streaks of
WMl/pACYC-regA/placZ-IIB cells.

42

43

binding. To see if these mutations had the same effects on RegA activity in vivo, three
plasmids containing mutations in the gene 44 RE on placZ-RE2 were created (see Figure
SB). These mutants were chosen because they were expected to produce different effects

on the binding affinity of RegA to the RE. The G-6 substitution was expected to weaken
the Shine-Dalgarno site of the RE with little effect on RegA binding. It was expected
that ribosomes would have less affinity for this site and RegA would therefore be able to
repress lacZ expression from this plasmid more efficiently. The G-7 substitution was
also expected to weaken the Shine-Dalgarno site but also reduced RegA' s affinity for the
RE by an order of magnitude, from approximately 107 to 10 6 M- 1• The previously
mentioned G-9 mutation was expected to reduce RegA's affinity for the RE to the level
of non-specific binding, and therefore, RegA should be unable to repress lacZ expression
from plasmids with this sequence as the target site. The mutation at G-7 was also
expected to reduce affinity for the gene 44 RE, but to a lesser extent than the G-9
mutation. The mutation at G-6 was made to weaken the Shine-Dalgarno site of the RE
without appreciably reducing RegA affinity for the gene 44 RE.
The placZ-G-6, G-7, and G-9 mutants were introduced into placZ-RE2 using the
QwikChange1M site-directed mutagenesis protocol. After mutagenesis and sequencing to
confirm the mutations, cells containing plasmids placZ-RE2, placZ-G-6, placZ-G-7, and
placZ-G-9 were plated on X-Gal plates to compare the level of ~-galactosidase expressed
from the various plasmids.

As shown in Figure 9, color development due to

galactosidase activity was highest in cells containing placZ-RE2.

~

Color intensity

decreased in cells with mutant plasmids in the following order, placZ-G-7, placZ-G-9,
and placZ-G-6. Based on these results it was concluded that plasmid G-6 did not produce

44

[8]

A

U

107

-

-

-

J

-

-

-

-

wild type
binding

_

non-specific
binding

C

....-.
,.I

~

106

---~

~

105
A

5'-

A

U

G

A

G

G

A

A

A

-12

[BJ

U

U

-3'

-1

GENE 44 mRNA

RECOGNITION ELEMENT
SEQUENCE VARIATIONS

X-GAL

X-GAL
IPTG

placZ-IIB/pREVl

TACAGGATTCAGACAACAAGATG

BLUE

BLUE

placZ-44RE/pREGA

TACAGGAT~AATGAGGAAATT~TG

BLUE

WHITE

placZ-44RE2/pREGA

TA~TTGAATGAGGAAATTATG

BLUE

WHITE

placZ-44RE2G-6/pREGA

TACCATATTGAATGA~TTATG

BLUE

WHITE

placZ-44RE2G-7/pREGA

TACCATATTGAATG~AAATTATG

BLUE

LT.BLUE

placZ-44RE2G-9/pREGA

TACCATATTGAA~GGAAATTATG

BLUE

BLUE

PLASMIDS

Predicted (olony (olor

Figure 8: (A) Effects of base substitutions in gene 44 on affinity of RegA protein
for gene 44 Recognition Element RNA in vitro. The G to C substitution at - 9 reduced
affinity to the non-specific level, while some other substitutions reduced affinity by an
order of magnitude (Webster and Spicer, 1990). (B) Variations of the gene 44RE on
placZ plasmids designed to generate mRNAs with differing affinities for RegA protein.
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placZ-G-7

placZ-G-9

placZ-RE2

placZ-G-6

Figure 9: Color development in cells transformed with placZ-RE2 and placZ-RE2
variants. Cells co-transformed with each of the placZ vectors were plated on LB/amp
plates with X-GAL. Cells containing placZ-RE2 show the darkest color while there is
little or no color in cells containing placZ-G-6. Cells containing placZ-G-7 and placZ-G9show similar color development but as a rule color intensity is as follows: RE2>G-7>G9>G-6. (Note: These cells do not contain pACYC-regA)
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enough B-galactosidase to be useful in an assay of RegA repression activity.

3. In vivo assay of RegA repression of gene 44 RE-lacZ fusion gene.
Beta-galactosidase assays were performed to determine if RegA protein's
differences in binding affinity in vitro for variant gene 44 RE binding targets coordinated
with RegA' s ability to repress gene expression from plasmids carrying the lacZ gene
fused to the different gene 44 RE variants. Cells containing placZ-RE2, placZ-G-7, and
placZ-G-9 were assayed along with cells containing placZ-lIB, which doesn't contain a
binding site for RegA, and cells containing placZ-44RE, which contains a stem loop
structure which interferes with RegA binding to the gene 44 RE. Cells containing each of
these plasmids were transformed with each of the plasmids, pREY!, pACYC-WTT4, and
pACYC-WTRB. Beta-galactosidase was assayed as described in the Materials and
Methods chapter. As shown in Table 2, B-galactosidase was most highly repressed in
cells containing the wild type gene 44 RE. Repression was reduced as expected from
plasmids containing each of the other targets.
B. Development of a screen for RegA mutants with altered RNA binding specificity
To further determine if placZ-G-7 and placZ-G-9 were suitable for use in the
assay of RegA activity, cells containing each of these vectors were transformed with
pACYC-regA and plated on X-Gal and X-GaIlIPTG plates.

Beta-galactosidase

expression levels appeared to be greatly reduced in cells containing placZ-G-9 and
pACYC-regA even without IPTG induction, therefore it was decided that the placZ-G-9
target would not be suitable for the blue-white screen. Cells containing placZ-G-7 and
pACYC-regA retained enough color that it was considered probable that these cells could
be used in the blue-white screen. Based on previous results of in vitro binding assays
which indicated that RegA did not efficiently bind to the G-9 target it was expected that

47

Beta-Galactosidase Assays
4/22/00

4/27/00

5/23/00

Miller

Repression

Miller

Repression

Miller

Repression

Units

Ratio

Units

Ratio

Units

Ratio

***

***

403
172

***

***

placZ-RE2 100 mM IPTG

1439

***

443
74
812

***

placZ-44RE 100 mM IPTG

366
177

***

1227

***

placZ-G-7 100 mM IPTG

137
108

***

113

***

***

***

59

***

327
199

0.9

66

679

0.7

79
624

6.7
0.9
1.3
0.8
0.3

338
195

0.6
0.8
1.0
1.0
1.1

1.1

671

0.6

0.5

287

0.6

2.7

438
467

2.8
0.7
1.3

Cell Type
placZ-IIB 100 mM IPTG

placZ-G-9 100 mM IPTG
placZ-IIB/pREV 1 100 mM IPTG
placZ-44RE/pREVI 100 mM IPTG
placZ-RE2/pREVl 100 mM IPTG

392
247
442

3.3

placZ-G-9/pREV 1 100 mM IPTG

294
284

placZ-IIB/pACYC-WTT4 100 mM IPTG

323

placZ-44RE/pACYC-WTT4 100 mM IPTG

279

0.5
0.4
1.1
0.6

placZ-RE2/pACYC-WTT4 100 mM IPTG

616
215
90

2.3
0.6
1.2

placZ-G-7/pREV 1 100 mM IPTG

pJacZ-G-7/pACYC-WTT4 100 mM IPTG
placZ-G-9/pACYC-WTT4 100 mM IPTG

141
195
396
155
304
296
24

0.4
2.4

210
1668

153

***

***

Table 2: Ji-Galactosidase assays of cells containing gene 44 -lacZ plasmids with
either pREVl or pACYC-WTT4 vectors. Miller units were calculated for each of the
cell types. The values for cells with the lacZ plasmid only were divided by the values for
cells with either pREY! or pACYC-WTT4 to calculate the repression ratio as an
indication of either RegA of Rev protein's ability to repress lacZ expression from the
plasmids containing the different gene 44 RE targets.
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the color of cells containing placZ-G-9 would be relatively unaffected by the presence of
the regA plasmid. These results indicate that the repression ability of RegA for specific
targets in vivo may be difficult to predict from in vitro binding assays. concluded the
placZ-G-7 vector was suitable for use in the blue-white screen. Cells containing placZG-7 were lighter in color that those containing placZ-RE2. It was hypothesized that some
mutant RegA proteins might be able to repress the less robust lacZ repression from G-7
but not be able to repress lacZ expression from placZ-RE2. As with placZ-RE2, the cells
containing placZ-G-7 or placZ-G-9 showed no significant difference in color
development between colonies grown on X-Gal plates and those grown on X-GaIlIPTG
plates.
1. Random Mutagenesis of the T4 regA gene
To generate the mutant library for the screen for gain of function mutants the regA
gene was randomly mutagenized and plasmids expressing the mutant regA gene were
transformed into cells containing one of the previously modified gene 44 RE-IacZ
vectors.

Subsequently colonies of cells transformed with defective gene 44 target

plasmids were to be screened for mutations in the regA gene that had regained the ability
to repress lacZ expression from the defective gene 44 RE and once again produce white
colonies on X-GAL/IPTG plates. RegA "gain of function" mutants were expected to
have either altered RNA binding specificity or generally increased RNA binding affinity.
For the purposes of this study mutants with altered binding specificity should give more
insight into how RegA protein is able to chose its RNA binding targets and repress the
expression of genes in the proper temporal sequence. Mutations which alter RegA' s
binding specificity would be more likely to result in a change in the temporal order of the
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genes repressed, and thereby, reveal more about the residues involved in interaction with
specific bases than would mutations which increase RegA' s binding affinity for all
targets.
In order to find "gain of function" mutants it was necessary to screen a large
number of mutant clones. Accordingly, PCR mutagenesis was used to create a library of
regA clones containing random mutations in the regA gene. The library was generated by
peR amplification of regA from pAS l-regA plasmid using identical primers to those
initially used to amplify wild type regA for cloning into pACYC-regA (see materials and
methods). A mutagenic PCR protocol with increased tolerance for the insertion of
mismatched bases was used to create random mutations in the regA gene (Cadwell and
Joyce, 1992). This protocol produces an average of one mutation for every 150-200 base
pairs of DNA; thus, approximately two mutations per regA gene (366 base pair coding
region) is expected from this protocol.
After amplification, the mutagenized PCR products were digested with N de I and
Sal I and ligated into pACYC-regA vector that had also been cut with Nde I and Sal I.
The QIAquick™ Gel purification protocol was used to purify the linearized vector away
from the restriction fragment containing wild type regA. The ligation mix was then
transformed into XL I-Blue super competent cells to maximize transformation efficiency.
The transformed cells were grown overnight in culture, plasmid DNA was extracted and
saved as a library for use in "gain of function" &creening.
For the initial screening of the mutant library WMI/placZ-RE2 cells were used as
a host. As noted previously WMl/F' /placZ-RE2/pACYC-regA (unmutated) colonies are
blue when grown on X-Gal plates and on X-Gal plates with low concentrations ofIPTG.
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It was expected that RegA mutants with increased affinity for the RE2 target would

"gain" the ability to repress lacZ expression in a placZ-RE2 background resulting in
white or lighter blue colonies grown on X-Gal or X-Gal/low [IPTG] plates.
WMI/F'/pACYC-RE2 cells transformed with the mutant library were plated on

both X-Gal and X-Gal/IPTG plates and grown overnight. The plates were then examined
for white or light blue colonies, as shown in Figure 10. The white or lighter blue colonies
were selected and grown in liquid culture overnight. Plasmid DNAs were extracted and
the plasmids were sequenced to identify the mutation responsible for the color change.
Plasmid DNAs extracted from cells transformed with the mutagenized regA gene were
labeled pACYC-MT4.
Five super repressor candidates were selected and sequenced, however, none of
the five contained the regA gene, mutant or wild type. These results suggested that the
lack of color initially attributed to RegA repression of lacZ was caused either by a
defective lacZ gene in the selected colonies or, more likely, the colonies were the result
of a contaminating bacterial strain that didn't express

~-galactosidase.

Since there was a

high probability of contamination this library was discarded and the mutagenesis was
repeated to create a new mutant library.
Also since it appeared that RegA was not efficiently repressing lacZ expression in
WMI/F' /placZ-RE2/pACYC-reg cells, the synthesis and solubility of RegA protein

inthese cells was examined. IPTG induced cells were lysed by freeze-thaw procedure,
and the supernatant and pellet were examined by SDS-PAGE. This analysis indicated
that the majority of the RegA protein was in the pellet. As noted previously, the pACYCregA plasmid expresses a fusion protein of T4 RegA which carries six residues from the
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X-Gal

X-Gal jlPTG

Figure 10: Screen for gain of function mutants. WMI/F IplacZ-RE2 cells were
transformed with pACYC-MT4 and plated on X-Gal and X-GaI/IPTG plates. White or
lighter blue colonies were selected as potential super repressors (i.e. gain of Function
mutants).
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Rev gene. It seemed possible that these six residues could interfere with the proper
folding of the RegA protein, and thus be responsible for the relative insolubility of the
protein encoded by pACYC-regA.

There was also some concern that the reduced

solubility of the fusion protein as compared to wild type RegA was adversely affecting
the blue white screen. The fraction of RegA protein that was misfolded would be unable
to bind the gene 44 RE effectively resulting in a lower RegA concentration within the
cell. Accordingly the six amino acid fusion was removed before proceeding with the
screening experiment.
As the first step in eliminating the six Rev amino acid residues from the Nterminus of RegA, site-directed mutagenesis was used to change two bases beginning at
the -2 position relative to the start codon from "AC" to "CA". This mutation resulted in
the creation of a new N de I site, "CATA TG", 18 base-pairs upstream from the original
Nde I at the beginning of the regA coding sequence. The new Nde I site was positioned
such that when the plasmid is digested with Nde I restriction enzyme the 18 base pairs
which encode the six Rev residues are excised from the plasmid. After religation with T4
ligase the sticky ends from the two original Nde I sites were joined to form a single new
Nde I site which restored the correct reading frame for regA. Following oligonucleotidedirected mutagenesis of pACYC-regA, cells were transformed with the mutagenesis
reaction, plated and grown overnight. Plasmid DNA was extracted and sequenced to
confirm that the resulting plasmid had the new mutation. The new plasmid was called
pACYC-regA-2Nde.
Next pACYC-regA-2Nde was digested with Nde I restriction enzyme to excise the 18
base pair sequence, and then religated to make the new plasmid pACYC-WTT4 (See
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Figure 11). Cells were then transformed with the ligation mix, piated, and grown
overnight.

Five colonies were selected and grown overnight. Plasmid DNA was

extracted and sequenced to confirm that the 18 nucleotide sequence had been deleted.
Three of the five plasmids were confirmed to have regA sequences without the six
additional amino acid residues attached to the N -terminus.

These three colonies

containing the new vector encoding wild type regA were grown in liquid cultures
overnight. Freeze-thaw assays were performed the following day with these cultures and
samples of the induced cells, uninduced cells, freeze thaw supernatant, and freeze thaw
pellets were visualized by SDS-PAGE.
When examined by SDS-PAGE, cultures three and five appeared to overexpress
T4 regA, but culture number four didn't appear to overexpress regA. The RegA protein
from T4 cultures three and five appeared to be soluble, although there appeared to be
much more regA protein in the supernatant of clone number five. There was also a very
faint band in the supernatant of culture number four. The induction and freeze-thaw gels
for these cultures are shown in Figure 12.
Since the SDS-PAGE of the freeze-thaw supernatants indicated that RegA protein from
both clones three and five were soluble, an EMSA was performed with supernatants of
clones three and five to see i[RegA protein retained the ability to bind to a 16 mer RNA
oligo containing the gene 44 RE. The results of this assay are shown in Figure 13. The
RegA protein in both supernatants bound to the labeled RNA and produced a shift in
mobility. These result indicate that the proteins from clones three and five are capable of
binding to the gene 44 RE oligonucleotide.
Since the wild type regA expressed from pACYC-WTT4 appeared both soluble
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Figure 11: Creation of pACYC-WTT4. PACYC-regA was modified by site-directed
mutagenesis to create pACYC-regA-2Nde. This plasmid contained 2 Nde I sites 18 base
pairs apart and encompassing the same 18 base pairs that coded for the 6 amino acid
residues fused to the N-terminus of RegA. The plasmid was then digested Nde I
restriction enzyme and religated to create pACYC-WTT4.
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Figure 12: Induction and Freeze-Thaw gels ofpACYC . . WTT4 and pACYC-WTRB.
Upper: SDS-PAGE of induced and uninduced cultures containing pACYC-WTT4 and
pACYC-WTRB. Cultures 3 and 5 overexpress T4 regA after IPTG induction but culture
4 does not. RB69 regA is overexpressed after induction but at a lower amount than T4
regA. Lower: SDS-PAGE of the freeze-thaw pellet and supernatant of cultures in upper
gel. T4 regA proteins in cultures 3 and 5 are soluble as is RB69 regA. The band in
culture 4 appears to run slightly higher in the gel than regA protein.
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Figure 13: Gel mobility shift assay of wild type T4 RegA. The supernatants of T4
RegA cultures three and four both cause a shift with the 32 p labeled RNA oligo of gene
44 RE, demonstrating the RegA proteins from these cultures are capable of binding the
gene 44 RE target.
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and capable of binding RNA, a new mutant library was generated. The same mutagenic
PCR and ligation protocol as used in the previous experiment was used to create the new
library. As the previous attempt had been unsuccessful in finding "gain of function'
RegA mutants in WMI/F' /placZ-RE2 cells, WMI/F' /placZ-G-7 cells were used for this
experiment. It was hoped that super repressor mutations could be found that would result
in white colonies when the library was screened.

2. Selection and Characterization of Potential "gain of function" Mutants.
After the peR the mutant regA product and pACYC-WTT4 plasmid were
digested with the restriction enzymes Nde I and Sal I, and subsequently both were gel
purified to remove unwanted DNA. Next, cut plasmid and regA insert were ligated
overnight with T4 DNA ligase. WMl/F' cells were transformed with the ligation mix,
plated on LB agar and grown overnight. Approximately 1000 colonies were screened on
16 transformation plates. Forty lighter blue or white colonies were selected as potential
super repressors.

These colonies were grown in 3 ml cultures overnight and then

streaked onto X-Gal and X-Gal/IPTG plates to confirm that these cells exhibited
differences in color. At the same time new cultures of each of the super repressor
candidates were grown to an OD of .800 and induced overnight for freeze-thaw lysis and
subsequent analysis by SDS-PAGE and EMSA. Additional cultures of each potential
super repressor were grown overnight for plasmid DNA extraction. After overnight
growth the streak plates were examined for color differences, induced samples were
examined using SDS-PAGE, and plasmid DNA was extracted and sequenced. The streak
plates and Induction gel for the first eight of the potential super repressors are shown in
Figure 14.
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Half of the potential super repressors shown in Figure 14 did not show a
difference in color when plated on X-GAL and X-GAL/IPTG plates. For the total group
of 40 potential super repressors almost two thirds of the clones did not contain an
inducible regA gene. Each of the inducible clones were sequenced, and three different
mutations were identified.

The three mutations were Valine 15 to Glutamic Acid

(VI5E), Alanine 75 to Glutamic Acid (A 75E), and a truncation at residue 106 (FI06X).
Isolates of each these three mutants were found multiple times. The highly expressed
clones shown in Figure 14 contain examples of each of the different mutants found in this
study. Clone number two is A 75E; clones three and four are both F I 06X; and clone
number five is VI5E.
Gel mobility shift assays were performed using the freeze-thaw supernatants of the three
mutants and surprisingly there was no detectable RNA shift indicating little or no binding
to the RNA target. Based on this assay and the high levels expression in the induced cells
it was decided that these mutants were not the expected "gain of function" mutants but
instead were mutants with a lower affinity for RNA. Repression of lacZ expression most
likely was achieved by overexpression of the mutants, made possible because the mutant
RegA were less toxic to the cells than wild type RegA. If so, the mutants had the ability
to repress lacZ expression, but not in a manner that could yield useful information about
the binding site of RegA protein for its RNA target.
C. Comparison ofT4 and RB69 RegA Proteins' Activities in vivo
Previous work by other researchers had shown that the RegA homologue found in
the bacteriophage RB69 could bind to T4 RNA binding targets, and suggested that RB69
RegA had a higher affinity for synthetic T4 gene 44 RE RNA than did T4 RegA itself
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Induction Gel
1

2

3

4

Figure 14: Identification of T4 mutants from blue-white screen. Upper: Streak plates
of potential super repressors from blue white assay of mutant library. Lower: Induction
gel of cultures grown from same colonies as shown on streak plates. Note that color
changes in streak plates correspond to highly induced clones on the gel.
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(Joswik and Miller, 1992; Sengupta et aI., 2000). Using gel mobility shift assays RB69
RegA protein's affinity for the T4 gene 44 RE RNA was calculated to be approximately
7-8 times that of T4 RegA (Sengupta et al., 2000). The higher affinity for the gene 44
target meant that RB69 RegA was, in essence, a super repressor when compared to T4
RegA. This suggests that RB69 RegA could possibly be used as a positive control for
super repressors in future experiments. To determine if the increased affinity of RB69
RegA for the gene 44 RE observed in vitro resulted in phenotypic differences in vivo the
RB69 regA gene was cloned into pACYC and the effects of RB69 RegA on lacZ
expression was examined.

1. Construction and Characterization ofpACYC-WTRB
The RB69 regA gene was amplified from the plasmid pJG4 and then ligated into
the pACYC plasmid with the same cloning procedure that had been used to create the
original pACYC-regA plasmid. First the RB69 regA gene was amplified from the
plasmid pJG4 with complementary primers that generated a Nde I/Sal I fragment
containing the RB69 gene. The RB69 regA PCR product and the pACYC plasmid were
both digested with Nde I and Sal I and gel purified to remove DNA fragments excised by
the digest. The RB69 gene was then ligated into pACYC with T4 ligase. The ligated
plasmid was transformed into XL I-Blue supercompetent cells, plated, and grown
overnight. Only one colony was generated from the transformation, but after extracting
the plasmid DNA, sequence analysis indicated the plasmid contained the wild type RB69
regA gene. The new plasmid was named pACYC-WTRB and subsequently transformed

into WMI/F' cells containing each of the following placZ plasmids: II B, 44RE, RE2, G7, and G-9. Following transformation, WMI/F'/placZ-RE2/pACYC-WTRB cells were
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induced with IPTG overnight and a freeze-thaw assay was performed. When induced
with IPTG the cells overexpressed RB69 regA, but at a lower level than T4 regA
expressed in identical WM1/F'/placZ-RE2/pACYC-WTT4 cells. SDS-PAGE analysis of
the freeze-thawed cells containing pACYC-WTRB also demonstrated a band for RB69
RegA, again indicating lower levels than in the cells expressing T4 regA. Since RB69
was expressed in a soluble form in these cells, an in vivo comparison of WM1/F' IplacZRE2 cells containing pACYC-WTT4 and pACYC-WTRB was made.

2. In vivo comparison of T4 and RB69 regA proteins' repression of gene 44
RE-lacZ expression.
As a preliminary comparison of the ability of RB69 and T4 RegA proteins to
repress lacZ expression, streak plates were made with side by side streaks of
WM1/F'/placZ-RE2/pACYC-WTT4 cells and WM1/F'/placZ-RE2/pACYC-WTRB

cells. The streaks were made onto 4 X-Gal plates with IPTG concentrations of 0, 10,
100, and 1000 J,lM. Unfortunately, the adverse selection for non-functional mutants made
determination of wild type RB69 protein's repression ability by color screening
unreliable. Therefore, these efforts were discontinued.
Alternatively, the ability of RB69 RegA to repress lacZ expression was compared
by

~-galactosidase

assays of liquid cultures. The same procedure was followed for this

assay as was used in the B-galactosidase assay with T4 RegA. The only difference was
the WM 1IF' cells containing the different placZ plasmids were transformed with
pACYC-WTRB instead of pACYC-WTT4. The results of these assays, shown in Table
3, demonstrate that RB69 RegA does show increased repression ability in comparison
with T 4 RegA. This increase in repression ability is demonstrated consistently with each
of the gene 44 RE variants tested. Comparison of the results shown in Table 3 with those
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Beta-Galactosidase Assays
4/22/00

4/27/00

5/23/00

Miller

Repression

Miller

Repression

Miller

Repression

Units

Ratio

Units

Ratio

Units

Ratio

placZ-IIB 100 mM IPTG

366

***

443

***

403

***

placZ-44RE 100 mM IPTG

177

***

74

***

172

***

placZ-RE2 100 mM IPTG

1439

***

812

***

1227

***

placZ-G-7 100 mM IPTG

137

***

113

***

327

***

placZ-G-9 100 mM IPTG

108

***

59

***

199

***

placZ-IlB/pREVl 100 mM IPTG

66
79
624

6.7

679

0.6

0.9
1.3

210
1668

0.8

placZ-RE2/pREVl 100 mM IPTG

392
247
442

placZ-G-7/pREVl 100 mM IPTG

294

141

0.8

338

1.0

placZ-G-9/pREV I 100 mM IPTG

284

195

195

1.1

placZ-IIB/pACYC- WTRB 100 mM IPTG

338

1.2

Cell Type

placZ-44RE/pREVl 100 mM IPTG

n.~

0_7

3.3

1.0

439

0.5
0.4
0.8

435

0.3
1.0

placZ-44RE/pACYC- WTRB 100 mM IPTG

161

1.1

148

0.5

205

0.8

placZ-RE2/pACYC- WTRB 100 mM IPTG

298

4.8

306

2.7

300

4.1

placZ-G-7/pACYC- WTRB 100 mM IPTG

228

73

257

1.5
0.7

189

placZ-G-9/pACYC- WTRB 100 mM IPTG

0.6
0.4

1.7
1.6

90

123

Table 3: Beta-Galactosidase Assays of Cells Containing Plasmids With Variant
Gene 44 REs only with or without pREVl or pACYC-WTRB. Miller units were
calculated for each of the cell types. The values for cells with the lacZ plasmid only were
divided by the values for cells with either pREY! or pACYC-WTRB to calculate the
repression ratio as an indication of either RegA of Rev protein's ability to repress lacZ
expression from the plasmids containing the different gene 44 RE targets.
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for T4 RegA shown in Table 2 demonstrate that the repression ability of RB69 RegA is
consistently greater than that of T4 RegA with each of the lacZ plasmids tested.

DISCUSSION
The study presented in this thesis was intended to provide new insights into how
RegA protein functions as a translational repressor. The objectives of this study were: 1)
to test whether the ability of regA to distinguish between wild type and selected variants
of the gene 44 RE is functionally relevant to in vivo repression of gene expression, 2) to
identify mutants of T4 RegA that have altered RNA binding specificity, and 3) to
determine whether differences between RB69 and T4 RegA proteins' repression of gene
44 in vitro are consistent with functional activities in vivo. Observations from the in vivo
studies described here, which were performed to answer these questions, have provided
new information concerning the function and behavior ofT4 RegA protein.
The T4 gene 44 recognition element confers sensitivity to RegA repression on
the LacZ gene in vivo.

Earlier studies of RegA protein binding to gene 44 mRNA

suggested that RegA recognizes a short, 12 nucleotide sequence upstream of the gene 44
AUG start codon (\\Tebster and Spicer, 1990).

To determine the contributions of

individual bases of the gene 44 RE to RegA binding affinity, (Webster and Spicer, 1990)
determined the in vitro binding affinities of RegA for selected gene 44 RE variants.
However, measured affinities of RegA protein for short synthetic RNAs may not be
directly related to repression activities observed in

vivo because of the effects of

neighboring nucleotides sequences or structures and unrelated effects on the affinity of
ribosomes which compete with RegA protein for binding to an mRNA. To see if the
results of previous studies of RegA protein affinity for short synthetic RNAs are
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reflective of RegA activity in vivo, the ability of RegA to act in trans to repress
translation of a gene 44 RE-IacZ fusion gene was explored. For these in vivo studies, the
ability of RegA to repress a fusion gene carrying the 12 nucleotide sequence
AAUGAGGAAAUU(AUG) fused to lacZ was studied. In addition, the ability of Reg A
to repress expression of a 0-9 variant of gene 44 RE was examined because in vitro this
mutation reduced the binding affinity of T4 RegA to that of non-specific RNA. The G-7
variant was selected because it demonstrated a binding affinity approximately halfway
between that of wild type and 0-9. Cells containing plasmids placZ-IIB and placZ-44RE
were also compared in this study. PlacZ-IIB served as a control because it did not
contain a binding site for RegA and placZ-44RE was included to determine the effect on
RegA binding of a

stem-loop structure which preceded the gene 44 RE .

The results of B-galactosidase assays performed with WM 1IF' cells carrying
pACYC-WTT4 and the placZ plasmids, lIB, 44RE, RE2, G-7, and G-9 are summarized
in Table 4. The data in Table 4 present the RegA repression ratios from a single
experiment and the average of three experiments presented in the RESULTS section,
above. As shown in Table 4, expression of RegA in cells containing the pLacZ-44RE2
vector led to a 2.6 fold repression of lac Z expression, while no repression was observed
in pLacZ-lIB cells or pLacZ-44 RE cells.

The lack of repression with pLacZ-lIB

demonstrates that the repression is specific for genes containing the gene44 recognition
element. The absence of repression with pLacZ-44RE indicates that the presence of a
stem and loop structure immediately preceding the gene 44 recognition element precludes
RegA repression of the fusion gene. Interestingly, introduction of a 0-7 mutation in the
gene 44 RE (Table 4) eliminated RegA repression, while the G-9 mutation in the
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recognition element reduced the repression ratio from 2.6 to 1.8. Although these are
only modest effects on repression, they are consistent with the predictions based on the
effects of single base substitutions in the gene 44 RE on in vitro RNA binding affinities.
Thus, these studies demonstrate that in the context of a full mRNA, RegA protein
recognizes the 12 nucleotide gene 44 recognition element and retains the ability to
distinguish between WT, G-9 and G-7 variant RNAs. This confirms that, unlike most
other translational repressors, RegA protein recognizes a short, single stranded RNA
sequence which is sufficient to confer sensitivity to translational repression in vivo.

Table 4. Repression of lacZ translation by T4 RegA protein.

Reporter plasmid
pLacZ-IIB
pLacZ-44RE
pLacZ-44 RE2
pLacZ-44G-7
pLacZ-44G-9

f3-galactosidase
activity'"
No RegA
pT4RegA
plasmid
366
323
176
279
1439
615
137
215
108
90

Repression
ratio*

Average
Repression
ratioC!)

1.1
0.6
2.3
0.6
1.2

0.9
0.6
2.6
0.6
1.8

'" ~-ga1actosidase activity is reported in Miller units.
*Repression ratios are the ratio of ~-galactosidase activity in cells containing pLacZ
vectors alone over activity in cells containing the pLacZ vector plus pRegA. Values are
from a single experiment.
C!) Values are the average of repression ratios from three experiments.

The toxicity of RegA protein for the host cells make the two-plasmid system
and blue-white screening procedure an unsuitable method for identifying "gain of
function" RegA mutants. As previously described, a two-plasmid system was designed
to allow the rapid screening of a large number of bacterial colonies expressing mutant T4
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proteins. Two major difficulties, which were not overcome, resulted in the determination
that this assay was not suitable for finding regA mutants with increase binding affinity.
The first problem was the adverse selection for RegA mutants with reduced RNA
binding affinity because of the toxicity of RegA protein for the host cells. This toxicity
necessitated the use of low levels of IPTG to induce RegA synthesis for these
experiments in an attempt to avoid killing cells containing functional RegA. In an effort
to find a level of gene induction that would not affect the growth of the cells and
therefore not select for the unwanted mutants, the growth curves of WMI/F'/placZRE2/pACYC-regA cells were measured at different IPTG concentrations and compared
with the growth of WMI/F'/placZ-RE2 cells without RegA. As shown in Figure 6, no
level of IPTG induction was found that did not affect cell growth. In fact even in the
absence of IPTG, the presence of the regA plasmid resulted in a significantly lower
growth rate than that observed in identical cells without the regA plasmid.
Although the toxicity of RegA was a concern it was felt that this problem could
be avoided by the use of low levels of IPTG for the screen. The mutation types expected
to result in white colonies were: 1) mutants with an overall increase in RNA binding
affinity and 2) mutants with an altered binding specificity resulting in increased affinity
for the particular gene 44 RE sequence contained in the lacZ plasmid. Either of these
mutant types could potentially be of interest or benefit in defining the binding site for
RNA on the RegA protein, but mutants with altered binding specificity would be of more
interest. Mutants of this type could give insight not only into the RNA binding site but
also to the method by which T4 RegA protein determines the hierarchy of its RNA
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binding preference. Mutants with reduced binding affinities were expected to be blue and
not interfere with the selection process.
The results of the experiments were different from those anticipated and this
difference demonstrated the second and more critical problem which made the blue-white
screen unsuitable for selecting mutants with increased binding affinity for RNA. Mutants
chosen using the blue-white selection process were not "gain of function" mutants. As
detailed above in the RESULTS section, a number of white or light blue colonies were
selected as potential gain of function mutants.

After additional screening and

characterization three different mutations were identified. For each of these mutants, a
freeze-thaw procedure was performed and the resulting supernatants were examined by
EMSA. There was no detectable RNA shift caused by these mutants. These results
suggest that even though the mutant proteins were able to repress lacZ expression in vivo,
their binding affinity was too low to be detected in normal gel shift assays. SDS-P AGE
analysis of the induced and uninduced mutant cells suggest that this repression is due to
the ability of the mutant proteins to be highly over expressed without harming the host
cells. Thus, the mutants selected in this assay do not appear to be informative for RegA
structure/functi on studi es.
RB69 RegA protein translationally represses a lacZ fusion gene carrying the
T4 gene 44 recognition element. The phylogenetically related RB69 phage encode a
RegA protein that is 220/0 divergent in sequence from T4 RegA protein. Earlier studies of
Joswik and Miller (1992) suggested that RB69 RegA protein is capable of repressing
phage T4-encoded mRNAs, including gene 44, gene 45 and rpbA.

These studies

suggested that RB69 RegA repressed the three T4 mRNAs, and protein synthesis in
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general, more efficiently than T4 RegA protein. Although the RegA recognition element
in RB69 gene 44 is not known, the sequence of the translation initiation region of RB69
gene 44 has three-nucleotide insertions relative to the T4 gene 44 TIR. To see if RB69
RegA protein recognizes the same sequence in T4 gene 44 as T4 RegA protein, the
ability of RB69 RegA to repress the translation of the gene 44-lacZ fusion gene carried
on placZ-44RE2 was examined. As shown in Table 5, below, the presence of RB69
RegA in cells carrying placZ-44RE2 resulted in repression of ~-galactosidase synthesis.
Thus, the 12 nucleotide sequence of T4 gene 44 confers sensitivity to repression by RB69
RegA.

Interestingly, this repression of gene44-lacZ was consistently higher than

repression by T4 RegA protein. This is in agreement with the higher affinity of RB69
RegA protein for gene 44 RE RNA measured in vitro (Sengupta et al., 2000) and the
report ofRB69 RegA repression ofT4 mRNAs by Joswik and Miller (1992).

Table 5. Repression of lacZ translation by RB69 RegA protein.
~-galactosidase

Reporter plasmid
pLacZ-IIB
pLacZ-44RE
pLacZ-44RE2
pLacZ-44G-7
pLacZ-44G-9

activity
No RegA
pRB69
RegA
plasmid

402
172
1226
327
199

338
205
300
189
123

Repression
ratio*

Average
repress10n
ratio\jl

1.2
0.8
4.1
1.7
1.6

1.0
0.9
4.0
1.2
1.3

.

*Repression ratios are the ratios of ~-galactosidase activity in cells containing
pLacZ vectors alone over activity in the same cells containing pRegA. Values are
from a single experiment.
\jI Values are the average of repression ratios from three experiments.
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As Table 5 shows, repression by RB69 RegA protein was significantly lower in
cells containing plasmids carrying the G-7 and G-9 mutations in the gene 44 RE. Thus,
although the two proteins have a number of divergent surface residues, these studies
suggest that RB69 regA protein shares

the ability of T 4 RegA protein to distinguish

between WT, G-7 and G-9 variants of the gene 44 RE. While the two proteins have
conserved helix-loop groove RNA binding motifs (Sengupta et al., 2000), presumably
some of the divergent residues contribute to the higher binding affinity for gene 44 RE
RNA seen here. These studies confirm the ability of RB69 RegA to repress

translation of T4 gene 44 mRNA in vivo and show, for the first time, that this
repression is conferred by the 12 nucleotide sequence 5'-AAUGAGGAAAUUA-3.
Additional studies will be needed to determine how RB69 RegA protein achieves the
higher affinity for T4 gene 44 RE than T4 RegA and how the differences in sequences
between T4 and RB69 mRNAs related to their repression in vivo.

CHAPTER II
I. INTRODUCTION
A. Aryl Hydrocarbon Receptor
1. Background and History
As early as the 1950's it was found that rodents exposed to polycyclic aromatic
hydrocarbons (PAHs) responded with what was then known as aryl hydrocarbon
hydroxylase (AHH) activity (Conney et aI., 1956; Schmidt and Bradfield, 1996). Genetic
studies revealed that AHH activity in response to PAHs varied greatly among inbred
mouse strains (Nebert and Gelboin, 1969), with C57 strains labeled as highly responsive
and DBA and AKR strains being considered non-responsive (Schmidt and Bradfield,
1996). Multiple alleles at a single locus were eventually determined to be responsible for
the variations in AHH response, and were termed the Ah locus (Green, 1973; Thomas
and Hutton, 1973; Schmidt and Bradfield, 1996).

It was later found that 2,3,7,8-

tetrachlorodibenzo-p-dioxin (TCDD) could elicit a vastly increased level of AHH activity
from the responsive strains and even elicit activity in the supposedly non-responsive
strains.

The existence of a soluble protein with receptor-like properties was first

confirmed using radiolabeled TCDD (Poland and Glover, 1976). The protein was termed
the aryl hydrocarbon receptor (AHR) since it was encoded by the Ah locus. Eventually
it

was

determined

that

an

AHR

was

also

expressed

In

non-
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responsive strains, although it exhibited significantly lower affinity for ligand than that
found in the responsive strains (Okey et al., 1989; Poland et al., 1994).

2. Localization and Protein Associations
The AHR is an ubiquitously expressed protein, and in the absence of ligand, is
generally found in the cytoplasm in an inactive multiprotein complex that minimally
consists of the AHR protein itself along with two molecules of hsp90 (Perdew, 1988;
Pollenz et ai., 1994: Holmes and Pollenz, 1997). Crosslinking, sedimentation, and other
experiments have also indicated the presence of an additional 37-43 kDa protein
associated with this complex (Chen and Perdew, 1994). Additionally, a 330 amino acid
protein with sequence similarity to a 52 kDa immunophilin co-activator of the
glucocorticoid receptor, has been shown to bind preferentially to ligand activated AHR
(Carver and Bradfield, 1997; Ma and Whitlock, 1997).
The AHR by itself is not sufficient to mediate gene expreSSIon through the
xenobiotic response elements (XREs).

Before this can occur, AHR must form a

heterodimer with the aryl hydrocarbon receptor nuclear translocator protein (ARNT). In
spite of its name, ARNT is not involved in the translocation of AHR to the nucleus.
ARNT is a constitutively expressed bHLH/PAS protein localized to the nucleus (Pollenz

et al., 1994; Hord and Perdew, 1994) where it exists as a homodimer. Although it was
initially discovered as a component of the AHR signal transduction pathway (Reyes et
aI., 1992), ARNT has been shown to form complexes with other bHLH/PAS proteins

such as SIM and HIF -1 a to mediate biological responses in those pathways (Li et al.,
1996; McGuire et aI., 1996).
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When activated by ligand, the AHR complex translocates to the nucleus. Once in
the nucleus the AHR protein can either dimerize with ARNT or be translocated back to
the cytosol. The AHRIARNT dimer mediates gene expression by binding to the XRE
(Jones et aI., 1986; Hankinson, 0, 1993; Whitlock, lR., 1993; Whitlock, J.R., 1999:
review articles).

The XREs are regions of DNA recognized by the AHR/ARNT

heterodimer. Multiple XRE sequences, (5'-TNGCGTG-3'), are located in the upstream
promoter region of all genes regulated by the AHR signal transduction pathway (Denison

et al., 1988; Denison et al., 1988). The CYP1A1 gene is the best known example of a
gene whose expression is mediated through AHRIARNT binding to XREs. Mutational
analysis has shown that the (5' -CGTG-3') motif is required for inducible AHRIARNT
dependent protein-DNA interactions at the enhancer site (Shen and Whitlock, 1992;
Whitlock, 1999). Additionally photo-crosslinking studies and mutational analysis have
indicated that AHR binds to the TNGC sequence of the enhancer, and that ARNT binds
to the GTG half-site (Bacsi et at., 1995).

3. Structure and Domains
AHR is a ligand-activated transcription factor that belongs to the growing family
of basic helix-Ioop-helixlPER-ARNT-SIM (PAS) proteins (Em a et al., 1992; Burbach et

aI., 1992, Whitlock, lP" 1999). In addition to the three namesake transcription factors,
other members of this family include a number of mammalian and Drosophila proteins
(Schmidt and Bradfield, 1996,), as well as the hypoxia inducible factor (HIF -1 a) and
coacti vator proteins such as Src-1 (Onate et al., 1995).
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Figure 15: Schematic View of the Functional Domains of the Aryl Hydrocarbon
Receptor: The AHR protein contains a number of domains which overlap in function.
The Basic region is the section of the protein primarily involved in DNA binding, but it
also encompasses the NLS sequence. This theme of overlapping function is again seen in
the helix-loop-helix region which is primarily responsible for the ability of AHR to
dimerize with its co-activatior ARNT. The NES sequence is contained within helix two
of this domain. The PAS region consists of the A and B boxes and again the theme of
overlapping function occurs. The B box functions in both ligand binding and Hsp90
binding. The Q- Rich region is rich in glutamines and is primarily responsible for the
transactivation ability of the AHR protein.
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The AHR can be divided into a number of functional domains or regIons (see
Figure 1). These domains include: 1) the N-terminal nuclear localization signal (NLS)
region, 2) the basic region, 3) helix-loop-helix domain, 4) the nuclear export sequence
(NES) region,S) the PER-ARNT-SIM (PAS) domain, 6) the ligand binding region, 7) the
hsp90 binding region, 8) the C-terminal transactivation domain. The regions are listed as
much as possible in their sequence order, N-terminus to C-terminus, although there is
some overlap. For example, the NES sequence is located on the second helix of the
helix-loop-helix domain.
The minimal NLS sequence for AHR has been identified as sequence of 27 amino
acid residues, numbering 13-39 in the protein sequence (Ikuta et aI., 1998).

This 27

residue sequence is described as a bipartite NLS (NLS signals are discussed in detail in
part 2 of the Introduction) with basic amino acid residues clustered at both the 5' and 3'
ends of the signal. Mutating either of the basic residues located at positions 13-15 or 3738 resulted in complete loss of translocation to the nucleus in experiments with this
sequence fused to green fluorescent protein (GFP) or glutathione S-transferase (OST)
(Ikuta et al., 1998).
The basic region and the helix-loop-helix (HLH) domain are often referred to as the
basiclhelix-Ioop-helix (bHLH) domain, but the two regions have distinct and separate
functions. The basic region consists of residues 27-39 (Burbach et al., 1992; Fukunaga et

aI., 1995) and is therefore completely overlapped by the NLS signal previously
discussed. It is this region that is responsible for the DNA-binding ability of the AHR
(Fukunaga et al., 1995). The HLH domain consists of residues 40-79. This domain has
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been shown to be necessary for dimerization with the co-activator protein ARNT
(Fukunaga et aI., 1995).
The NES region or signal, as previously mentioned, is located inside the HLH
domain. This is a leucine rich sequence of amino acid residues and is located on the
second helix of the HLH domain. The residues included are numbered 63-73 with the
sequence KLDKLSVLRLS (Gerace, 1995; Ikuta et al., 1998; Davarinos and Pollenz,
1999).
The PAS domain includes amino acids 120-384 and contains two 51 amino acid
repeat sequences of high similarity to regions found in the PER, ARNT, and SIM
proteins (Burbach et al., 1992). The PAS part of this region consists of the two repeat
sequences, PAS A and PAS B, but region also encompasses the hsp90 binding domain
and overlaps most of the ligand binding region. The PAS domain has also been shown to
be important in dimerization (Fukunaga et al., 1995). Deletion analysis has mapped the
hsp90 binding region to an area including amino acid residues 162-374, and the ligand
binding region to residues 230-397 (Fukunaga et aI., 1995).

Once again areas of the

protein responsible for differing functions overlap.
The C-tenninal transactivation domain is, as the name implies, responsible for the
transactivation properties of AHR. This region includes a glutamine rich sequence and
surrounding sequences. Deletion analysis has shown the amino acid residues 490-805 to
be necessary for transactivation (Fukunaga et aI., 1995). Other studies of the carboxy
half of the AHR have shown similar though not identical results (Dolwick et aI., 1993;
Whitelaw et aI., 1994)
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4. Degradation

It has been shown that ligand binding results in the rapid depletion of the AHR
protein both in vivo and in vitro. AHR protein is reduced by 80-95% in numerous cell
culture models within four hours of TCDD exposure and AHR protein remains depleted
as long as ligand is present in the media (Pollenz, R.S., 1996; Giannone et a!., 1995;
Giannone et al., 1998).

In vivo experiments have also shown AHR protein to be

dramatically reduced in the following: male reproductive tissues, spleen, thymus, liver,
and lung of rats given a single oral dose of TCDD (Pollenz et a!., 1998). AHR was also
shown to be reduced in male reproductive tissues of rats exposed to TCDD in utero and
lactationally (Sommer et a!., 1999).
In experiments with cultured cells, western blot analysis has shown that the AHR
protein concentration detected in nuclear lysates is highest following one hour of TCDD
exposure but then rapidly declines (Pollenz et aI., 1994; Pollenz, R.S. 1996).
Additionally, gel mobility shift analysis shows that the association of the AHR-ARNT
complex with the XRE is transient and the number of complexes associated with the XRE
is greatly reduced in cell culture models within 2-6 hours after ligand exposure (Pollenz et
aI., 1998; Reick et al., 1994).

Recent studies with cultured cells treated with dioxin and the proteasome inhibitor
MG-132 have shown that degradation of the AHR protein is inhibited in MG-132 treated
cells (Davarinos and Pollenz, 1999). These results indicate that AHR degradation occurs
in the cytoplasm, via the proteasome, after being exported from the nucleus.
Furthermore, treatment of cells with leptomycin B, a global inhibitor of nuclear export,
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prevents the rapid degradation of the AHR protein, and results in a sustained
accumulation of AHR in the nucleus of a number of different cell types (Davarinos and
Pollenz, 1999). Results similar to those seen with leptomycin B treatment were also
obtained using AHR proteins with non-functional nuclear export sequences (NES)
(Davarinos and Pollenz, 1999; Pollenz and Barbour, 2000).
Additional new studies have shown that the AHR protein degradation is inhibited
by treatment of cells with cyclohexamide with resulting superinduction of CYP 1A 1 gene
expression (Ma et aI., 2000). However, cyclohexamide has been shown to block protein
synthesis at the concentrations necessary for superinduction and inhibition of AHR
degradation. This information has led to the hypothesis that cyclohexamide treatment
blocks the synthesis of a protein necessary for the degradation of AHR putatively called
AHR degradation promoting factor (ADPF) (Ma et aI., 2000).

Further studies have

shown that AHR is targeted for degradation by ubiquitin and that blocking
ubiquitinization produced similar results to those obtained in cells treated with the
proteosome inhibitor MG-132 (Ma and Baldwin, 2000).
These multiple observations that AHR protein must re-translocate to the cytoplasm, and
that AHRIARNT dimers bound to DNA increase when export to the cytoplasm is
blocked give new insight and greater detail to the AHR signal transduction pathway (see
Figure 2).

These observations combined with the information that CYPIAI gene

expression is increased when AHR degradation is inhibited also suggest that the that the
degradation of the AHR may be an additional mechanism for the regulation of gene
expression via this pathway.
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Figure 16: Graphic representation of the Aryl Hydrocarbon Pathway: Prior to
agonist exposure AHR exists as an inactive multiprotein complex in the cytoplasm of the
cell. Upon introduction of agonist the AHR complex translocates to the nucleus. Inside
the nucleus AHR can dimerize with its co-activation partner ARNT. The AHRIARNT
complex can then bind to the XRE sequence and induce gene expression. Alternatively
the AHR protein can be exported back to the cytoplasm where it is degraded by the
proteosome.
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B. Nuclear transport
1. General overview
Nuclear export and import are both major cellular processes. All nuclear proteins
are made first in the cytoplasm and then must be imported into the nucleus while almost
all RNA molecules and messages must be exported to the cytoplasm for translation. Still
other proteins are thought to shuttle continuously between the nucleus and cytoplasm.
Conservative estimates have suggested that more than one million macromolecules are
transferred between the two compartments each minute in a growing mammalian cell
(Gorlich and Mattaj, 1996; Mattaj and Englmeier, 1998). All of this traffic is believed to
pass through the nuclear pore complexes (NPCs), which are huge structures that form
aqueous channels penetrating the double lipid bilayer of the nuclear envelope (Mattaj and
Englmeier, 1998).

The NPCs are huge structures consisting of 50-100 individual

polypeptides generically referred to as nucleoporins (Rout and Blobel, 1993). Together
these proteins form a channel that permits the diffusion of small molecules and even some
proteins smaller than 60 kDa approximately nine nanometers in diameter.
Although diffusion of small proteins and RNAs is possible, in practice there are
few proteins and no RNAs that are known to do this.

Instead, nuclear transport, of

proteins and nucleic acids, is accomplished primarily by active transport, an energy
dependent process that is essential for transport of RNA and protein across the nuclear
membrane (Daneholt B., 1997; Mattaj and Englmeier, 1998). The pore size for active
transport through the NPC is almost triple in diameter, 25 nanometers, when compared to
that of unassisted transport or diffusion, nine nanometers (F eldherr et al., 1984; Mattaj
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and Englmeier, 1998). Large conformational changes in the NPC must occur to allow
transport of larger molecules.
As one can imagine an important aspect of nucleocytoplasmic transport is making
certain that the molecules undergoing transport end up in their proper location in the cell.
Nuclear proteins must be localized to the nucleus and cytosolic proteins must find their
way to the cytosol so that they may perform their proper functions. Some proteins, the
previously discussed AHR for example, must move from one cellular compartment to
another to function properly. Cells have evolved mechanisms to insure that the various
proteins are in their proper location within the cell.

Energy in the form of ATP is

required to allow the necessary changes in conformation (Michael et aI., 1995; Shulga et

aI., 1996)

2. Nuclear Import
Proteins are targeted to the nucleus by means of a Nuclear Localization Signal
(NLS). While proteins use a number of different signals to direct their translocation into
the nucleus two of the better defined signals are: 1) the simple basic NLS typified by the
SV40 large T antigen NLS and, 2) the bipartite basic NSL similar to the nucleoplasmin
NLS (Kalderon et al., 1984; Mattaj and Englmeier, 1998). A number of other signals such
as the M9-domain, a glycine and aromatic rich region, found in human hmRNP AI, and
the KNS found in human hmRNP K have been identified but, as yet, are not completely
characterized or understood (Mattaj and Englmeier, 1998).
While the NLS is the tag that targets a protein to the nucleus, the process of
nuclear import is mediated through the action of a number of nuclear pore associated
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receptor and adapter proteins collectively known as importins. Two of the better known
and characterized proteins of these types are, importin a (adapter), and, importin ~,
(receptor). Importin a was first identified as a protein found in reticulocyte lysate that
could be crosslinked to the SV40 Tag NLS, and that functioned in nuclear import with a
second protein (Adam et af., 1989; Adam and Gerace, 1991; Adam and Adam, 1994;
Mattaj and Englmeier, 1998). In later studies first importin a and then importin b were
cloned (Gorlich et af., 1994; Enenkel et al., 1995). These two proteins form an

a/~

heterodimer and the importin a subunit binds to the NLS region of the protein to be
transported, and the importin

~

interacts with the NPC (Adam et af., 1989; Adam and

Gerace, 1991; Adam and Adam, 1994; Moore and Blobel, 1992; Gorlich et af., 1995;
Moroianu et af., 1995; Mattaj and Englmeier, 1998).
protein/importin

a/~

While formation of the

complex and docking with the NPC is energy independent, the

actual translocation to the nucleus is energy dependent (Richardson et al., 1988;
Newmeyer and Forbes, 1988). Ran GTPase and a number of other proteins are required
for GTP hydrolysis and translocation to the nucleus (Mattaj and Englmeier, 1998). Ran
with GTP bound binds to importin

~

and releases the imported protein from the importin

complex.

3. Nuclear Export
While nuclear import most likely consists primarily of the transport of individual
proteins or protein complexes, this does not hold true for nuclear export.

Since all

proteins are transcribed in the cytoplasm, a major function of nuclear export involves the
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translocation of RNA molecules to the cytosol. The export of the RNA molecules has
been shown to be mediated by adaptor proteins that bind to the RNA molecules and are
in tum recognized by the nuclear export proteins or exprotins, such as CRM 1 and CAS 1
(larmolowski et al., 1994; Pokrywka and Goldfarb, 1995; Mattaj and Englmeier, 1998).
The best understood model of nuclear export proposes that a protein or proteinRNA complex containing an NES associates with an export receptor such CRMI or
CAS 1. Both CRM 1 and CAS 1 have been shown to be distantly related to the importin

f3 protein.

CRM-l binds, cooperatively with the Ran GTPase (Fomerod et al., 1997), to

the NES of the protein being exported to the cytoplasm, and the entire complex then exits
the nucleus through the nuclear pore (Gerace, 1., 1995; 1995; Fomerod et aI., Cell, 1997;
Stade et al., 1997; Fomerod et al., EMBO, 1997; Kudo et ai., 1998; Kudo et al., 1997).
The protein then dissociates from the Ran, also with the aid of GTP hydrolysis
(F omerod et al., 1997).
The putative NES for CRM 1 mediated transport has been shown to be a sequence
of 10-12 amino acids rich in leucine (xLxxLxxLxLx) (Fomerod et al., 1997). This sequence
has been shown to directly associate with CRM -1 and has been found in proteins like
Rev and PKI (Fomerod et aI., Cell, 1997; Fukuda et al., 1997; Stade et al., 1997). The
function of nuclear export appears to be dependent on the function of the protein
containing the NES sequence, but a theme is developing in which nuclear export functions
to deliver active nuclear transcription factors to the cytoplasm for degradation. Examples
of this type of mechanism include the p53 protein where function is controlled in part
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through nuclear export and subsequent degradation by cytoplasmic proteases (Freedman
and Levine, 1999; Tao and Levine, 1999; Tao and Levine, 1999), and the cyclin dependent
kinase, p 27Ki pl (Sherr, C.l., 1996). The common theme in both pathways is that the export
of the affector protein from the nucleus results in reduced levels of gene regulation since
the protein is being removed from its site of action.
Recently it has been clearly established that the AHR protein is rapidly degraded
both in vivo and in vitro subsequent to agonist binding (Pollenz, R.S., 1996; Giannone et

al., 1998; Giannone et ai., 1995; Pollenz et al., 1998; Roman et al., 1998; Sommer et aI.,
1998).

It has also been shown that the AHR contains a putative NES sequence

(Davarinos and Pollenz, 1999; Ikuta et aI., 1999; Pollenz and Barbour, 2000). Thus,
studies have been performed to establish the relationship between the nuclear export of
the AHR and protein degradation. The studies have shown that blockage of AHR
degradation through inhibition of the 26S proteasome results in i) increased levels of AHR
in the nucleus, ii) increased levels of AHRIARNT complexes associated with DNA, and
iii) increased levels of gene induction following exposure to 2,3,7,8 tetrachlorodibenzo-pdioxin (Davarinos and Pollenz, 1999). In addition, studies have shown that when nuclear
export of the AHR is blocked by the fungal antibiotic leptomycin B (LMB), the AHR is
accumulated within the nucleus following ligand binding and is not degraded efficiently
(Davarinos and Pollenz, 1999). Taken together, these findings support the hypothesis
that nuclear export is required for the ligand bound AHR to be degraded and this type of
biological mechanism is consistent with the mechanism involved in the degradation of p53
and P27Kipl.
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The purpose of the studies detailed in this thesis was to further evaluate the
function of nuclear export and import of the AHR with focus on the relationship between
nuclear export and AHR-mediated gene regulation. The studies show that it is possible to
generate AHR proteins with mutations in the NES that dimerizes with ARNT, binds
DNA and supports

ligand-mediated gene induction. However, the studies also

demonstrate that treatment of cells with LMB results in inhibition of AHR-mediated gene
regulation even though high levels of AHRIARNT complex are bound to DNA. Thus, the
results indicate that there is a clear relationship between nuclear export and AHRmediated gene regulation, but that the relationship is complex and involves mechanisms
that are directly and indirectly related to the AHR protein. The experiments with NLS
mutants showed that these mutants retained functionality at the level of DNA binding,
and thus were likely to be capable of inducing gene expression. Additionally, the NLS
mutants were degraded more slowly after agonist exposure than wtAHR suggesting
another level of regulation of the AHR pathway.

II. SPECIFIC AIMS

The purpose of the studies detailed in this thesis was to generate plasmids that
encoded AHR mutant genes that could be used to study the behavior and significance of
the following aspects of the AHR pathway: 1) nuclear export of AHR protein, 2) nuclear
import of AHR protein, and 3) real time movement of AHR between the nucleus and the
cytoplasm. To accomplish these goals the specific aims listed below were established for
this study.
1.

Create a plasmid that encodes mutant AHR protein deficient in nuclear

export but unimpaired in ability to dimerize with ARNT and induce gene expression by
binding to the XRE.
2.

Create a plasmid that encodes mutant AHR protein deficient in nuclear

import but unimpaired in ability to dimerize with ARNT and induce gene expression by
binding to the XRE.
3.

Create a plasmid that encodes an AHR-GFP protein but unimpaired in

ability to dimerize with ARNT and induce gene expression by binding to the XRE.

III. MATERIALS AND METHODS
Chemicals

TeDD (98% stated chemical purity) was obtained from the Radian Corp. (Austin, TX)
and was solubilized in dimethyl sulfoxide (DMSO).
Buffers

Phosphate-buffered saline (PBS) is 0.8% NaCI, 0.02% KCI, 0.14% Na2HP04, 0.02%
K2HP04, pH 7.4.

Sample buffer is 125 mM Tris, pH 6.8,4% SDS, 25% glycerol, 4 mM EDTA, 20 mM
dithiothreitol, 0.005% bromphenol blue.

Tris-buffered saline is 50 mM Tris, 150 mM NaCI, pH 7.5
Tris-buffered saline with Tween 20 is 50 mM Tris, 0.20/0 Tween 20, 150 mM NaCI,
pH 7.5.

Tris-buffered saline with Tween 20+ is 50 mM Tris, 0.5% Tween 20, 300 mM NaCI,
pH 7.5.

BLOTTO is 5% dry milk in Tris-buffered saline with Tween 20.
Gel shift buffer (5X) is 50 mM Hepes, pH 7.5, 15 mM MgCI2, 500/0 glycerol.
Tris borate-EDTA is 45 mM Tris borate, 1 mM EDTA.
Antibodies -- All antibodies are affinity-purified IgG fractions. For Western blot analysis
goat anti-rabbit antibodies conjugated to horseradish peroxidase (GAR-HRP) were
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utilized .. This reagent was purchased from Jackson Immunoresearch (West Grove, PA).
Polyclonal rabbit -actin antibodies were purchased from Sigma.

Quantitative Western Blot Analysis ofAHR and ARNT-Protein samples were resolved by
SDS-PAGE and electrophoretically transferred to nitrocellulose.

Immunochemical

staining was carried out by primary antibody in BLOTTO. Normally blots were washed
three times in TTBS+ for a total of 45 minutes. The blot was then incubated for one hour
in BLOTTO with GAR-HRP and washed with TTBS+ as previously described. ECL
exposures were scanned into a Power Macintosh computer utilizing an HP Scanjet II

cm

with Adobe Photoshop ™ software. Images were quantified utilizing NIH image 1.55
software. The raw level of AHR protein was then divided by the level of ~-actin protein
to generate normalized values for the concentration of the AHR in each sample

Electrophoretic Mobility Shift Assay-A double-stranded XRE fragment corresponding to
the consensus XRE-l of the CYPIAI promoter was labeled with [a- 32 P]dCTP by
Klenow. Approximately 10-20

~g

of nuclear extract were then incubated at 22°C for 15

min in gel shift buffer supplemented with KCI (80 mM) and poly( dI-dC) (0.1 mg/ml).
Approximately 4 ng of 32P-Iabeled XRE were then added to each sample, and the
incubation was continued for an additional 15 min at 22°C. The samples were resolved
on 5% acrylamide, 0.5% Tris borate-EDTA gels, dried, and exposed to film.

In Vitro Mutagenesis -Site-directed mutagenesis All mutagenesis for this project was
performed with this Stratagene QwikChange™ kit. Mutagenic primers (25-45 bases long)
were designed as complementary pairs so that a primer would anneal to each strand on
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the template.

The desired mutation was situated in the center of the prImers.

prImers were synthesized by MUSC's Biotechnology Resource Laboratory.

The
The

lyophilized primers were resuspended in 1 ml 20 mM Tris-HCI, pH 7.5. In thin-walled
PCR tubes, IX reaction buffer (10 mM KCI, 6 mM (NH4)2S04, 20 mM Tris-HCI, pH 8,
2 mM MgCh, 0.1 % Triton® X-I00, 10 mg/ml nuclease-free BSA), 100 ng plasmid
template, 125 ng mutagenic primers, and 0.20 mM dNTPs were mixed and diluted to a
final volume of 50 J.lI with distilled water. To each mutagenesis reaction, 2.5 units (U) of

Pfu DNA polymerase was added for the amplification of the plasmid. The samples were
then placed in a thennocycler for the PCR.
After mutagenesis, the parental plasmids were digested for 1-2 hours at 37°C with
10 or 20 U of Dpn I restriction enzyme.

Dpn I digests only methylated DNA.

The

template DNA was extracted from E. coli cells and methylated by the cells natural
methylation enzymes.

The mutagenized plasmids are PCR amplified copies of the

template and, therefore unmethylated.

After Dpn I digest the uncut plasmid was

transformed into XLI-Blue supercompetent cells.

IV. RESULTS

AHR has been shown to possess putative export and import signals, and as
previously discussed recent experiments have shown that AHR is degraded by the 26S
proteasome (Davarinos and Pollenz, 1999: Ma et a/., 2000). This degradation has
also shown to be inhibited when nuclear export is blocked by the fungal antibiotic LMB

(Davarinos and Pollenz, 1999). The experiments detailed in this thesis were performed
in order to gain greater insight into the role or lack thereof for nuclear import andlor
export in the degradation of AHR subsequent to ligand exposure.
Although data from earlier experiments had shown that LMB blocked nuclear
export, and thus, inhibited degradation, there remained the possibility that degradation
was blocked by some means other than the prevention of AHR export to the cytoplasm.
Since LMB is a general inhibitor of nuclear export, and LMB is an exogenous substance
with potentially unknown effects on cellular metabolism the following hypotheses
remained to be tested. 1) Is degradation of AHR inhibited by LMB because the transport
of a protein other than AHR itself was blocked? 2) Is degradation of AHR inhibited
through some action of LMB exerted directly on the 26S proteasome degradation
pathway? To investigate these possibilities the following procedures were performed.
A. NES Mutants
1. Creation of NES Mutants
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Site-directed mutagenesis of the AHR NES was used to generate mutants that
were deficient in the ability to be exported from the nucleus, thus eliminating the need to
use LMB to block nuclear export. The putative NES of the AHR is a leucine rich
sequence (LDKLSVLRL) located between amino acid 63-71 in the proximal region of the
helix number 2 of the helix-loop-helix domain (Gerace, 1995; Ikuta et aI., 1998; Davarinos
and Pollenz, 1999). Microinjection experiments with proteins containing residues 55-75
of AHR fused to green florescent protein (GFP) have shown that this sequence is
sufficient to target the fusion protein for export to the cytoplasm (Ikuta et aI., 1998).
Additionally in these experiments it was shown that fusion proteins with mutations
leucine to alanine at residues 69 and 71 of the AHR sequence were no longer able to target
the fusion protein for export from the nucleus. Based on these reports it was decided to
mutate the NES for experiments with full length AHR.
Because of the multiple and overlapping functions of AHR protein there were additional
factors to be considered other than the ability of the AHR mutants to be exported. The
helix-loop-helix region which encompasses the AHR NES is also involved in dimerization
of bHLH/P AS proteins (Fukunaga et al., 1995). Therefore, it was necessary insure that a
mutation made to inhibit nuclear export, did not also inhibit the protein's ability to form
dimers with its co-activator protein, ARNT. To avoid this problem, the helix-loop-helix
domains of several ARNT binding bHLH/PAS proteins were compared to define which
residues were most highly conserved and therefore, less likely to be good candidates for
mutation. Sequence alignment showed that 5 of the 9 amino acids of the AHR NES were
conserved between hypoxia factor 1a, (HIF -1 a), the single-minded protein (SIM), and
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Figure 17: Sequence Comparison of Helix 2 of Basic Helix-Loop-HelixIPAS
Proteins: Comparison of the helix 2 region of for bHLH/PAS proteins, HIF-la, SIM,
NP AS, and AHR show that 5 residues corresponding to those found in the AHR NBS are
100% conserved in the four proteins. Additionally the first leucine is conserved in 3 of
the four proteins. The second leucine of the AHR NES is not found in any of the other
proteins but is actually conserved in the other three proteins as an alanine residue. The
third leucine is not conserved in any of the compared sequences. Leucine number four is
conserved in all four proteins. Based on this information Leucines two and three were
chosen for mutations as it seemed likely that these residues would be less likely to affect
AHR dimerization with ARNT. The ARNT sequence is shown below for comparison
with that of its dimerization partners.
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the nuclear PAS protein (NPAS). Since these proteins have not been shown to undergo
nuclear export it seemed likely that the conserved residues could be important for protein
dimerization (Figure 3). Importantly, only the leucine residues that bracketed the AHR
NES (positions 63 and 71) were conserved among all the proteins while leucine 66 was an
alanine in the other sequences and the residues that aligned to leucine 69 were valine,
isoleucine or methionine. Therefore, leucine 66 and 69 were deemed less important for
dimerization activity and were selected for mutation.
Based on the infonnation from the comparison of other bHLH/P AS proteins and
the reported results from the AHR NES-GFP fusion studies, four AHR NES mutants
were generated by site-directed mutagenesis. These mutations were: 1) AHR6,NES, 2)
AHR A66, 3) AHRA69 , 4) AHRAM ,. AHR6.NES contains leucine to alanine substitutions at
amino acids 69 and 71 (Figure 4). These mutations are identical to those in the AHR
NES-GFP fusion proteins which were shown to be retained in the nucleus (Ikuta et aI.,
1998). Although this mutation had been shown to be effective in inhibiting nuclear export
in the fusion proteins, comparison of the NES regions of other bHLH/PAS proteins
showed leucine 71 to be conserved in each of the proteins compared. This infonnation
suggested that it was likely that this mutant could be deficient in its ability to dimerize
with ARNT. AHRA66 contains a leucine to alanine substitution at amino acid 66. In the
three other bHLH/PAS proteins compared in Figure 3 this residue was an alanine, thus it
seemed likely that this mutation would not interfere with the ability to dimerize with
ARNT. AHRA69 contains a leucine to alanine substitution at amino acid 69. Alanine was
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NES Mutants
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Figure 18: Comparison of NES Mutants With Wild Type AHR: Mutant AHR NES
sequences are compared to the wild type AHR NES and the consensus NES sequence.
AHRA66 mutates the second leucine residue to alanine. AHRA69 mutates leucine number
three also to alanine. AHRAM is a double mutant with the second leucine changed to
alanine and the third leucine changed to a methionine. This mimics the sequence found in
the dimerization domain of the bHLHIP AS protein HIF -1 <l. AHRt1NES is also a double
mutant with leucines three and four changed to alanines.
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chosen as the mutation for this residue because this was one of the residues that was
mutated in AHR NES-GFP fusion protein which deficient in nuclear export. Also
comparisons with other bHLH/P AS proteins did not indicate a preferred residue at this
position.

AHRAM contains a leucine to alanine substitution at amino acid 66 and a

leucine to methionine substitution at amino acid 69. These amino acid changes were made
so that AHRAM showed 100% identity to the HIF-la protein from amino acids 64-71. It
seemed highly unlikely that a mutant with a this sequence would fail to dimerize with
ARNT, since HIF-la itself dimerizes with ARNT.

2. Characterization of NES Mutants
After generation of plasmids expressing AHR proteins with mutated NESs the
functional abilities of the new AHR proteins were examined. To compare dimerization
and DNA binding functions of the four NES mutants with that of wild type AHR
(wtAHR), AHRA66 , AHRA69 , AHRAM ,

AHR~NES,

and wtAHR proteins were expressed in

vitro and quantified by Western blotting. In vitro assays were performed first to
determine which mutant AHRs would be most suitable for in vivo studies, and to study
the function of these proteins without the added variable of nuclear export. Equal
amounts of each AHR protein were mixed with equal amounts of ARNT protein and the
sample was incubated in the presence of TCDD or DMSO for 2 hours at 30°C. After
incubation a [32p]dCTP labeled double stranded XRE probe was added to each mix and
then the new mixtures were incubated for an additional 15 minutes. The formation of
AHRIARNT-XRE complexes was then evaluated by electrophoretic mobility shift assay
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(EMSA) (Figure 4). Each of the AHR NES mutants exhibited some level ofTCDDdependent binding to the XRE when compared to the wtAHR protein. However, the
ability to bind the XRE varied greatly between the AHR mutants.

AHR~NEs,

as was

suggested by the comparison of bHLH/PAS sequences, showed the least ability to bind
the XRE at only 18% of the level of wtAHR. AHRA66 and AHRMA each bound only to
approximately 50% of the level ofwtAHR. These results were somewhat unexpected
since the residues corresponding to leucine 66 of AHR were already alanines in the other
bHLH/P AS proteins, and as previously discussed, the leucine 71 to methionine mutation
also mimicked the sequence ofHIF-la. Finally, the AHRA69 protein appeared to
function at about the same level as the wtAHR in the context of the in vitro EMSA
assay. This result was not unexpected since the comparison ofbHLH/PAS sequences had
shown a different residue at this position for each protein. Immunoprecipitation
experiments indicated that the variation in the levels of DNA binding observed in the
EMSA could be explained by the variations in the levels of dimerization of the different
AHR proteins. These results show that the AHRA69 protein exhibits TCDD-dependent
function at the level ofwtAHR in dimerization and DNA binding in vitro. However,
substitutions at residues 66 or 71 appear to negatively affect AHR function in
dimerization and DNA binding in vitro. That these results were obtained in vitro
suggests they are independent of any nuclear export function of the proteins. The ability
of AHRA69 to function at wild type levels indicated that it was the mutant best suited for
further experiments to study the effects of inhibition of nuclear export of the AHR
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EMSA of AHR NES Mutants
+ TCDD

+DMSO

AHR.ARNT ~

FREE ~,
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Figure 19: EMSA of wild type AHR and AHR mutants: The EMSA shown below
illustrates the comparative binding abilities of the AHR mutant proteins with that of wild
type AHR.
Densitometry was performed to calculate the relative number of
AHRIARNT /XRE complexes formed by each protein. The results are graphically
illustrated below. AHRA66 and ARRAM formed complexes at a level approximately 50%
that of wtARR. AHRA69 levels were similar to those of wtAHR and AHR~NES fonned
complexes at only 18% that of wtAHR.
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protein.

Therefore, AHR A69 was chosen to be used in microinjection experiments to

detennine if the mutant protein was deficient in nuclear export, and in experiments with
cultured cells to examine the effects of inhibition of nuclear export in vivo.

B. NLS Mutants
1. Creation of NLS Mutants
As previously discussed, in the absence of ligand, AHR is generally found in the
cytoplasm in an inactive multiprotein complex that minimally consists of the AHR
protein itself along with two molecules of hsp90 (Perdew, 1988; Pollenz et aI., 1994:
Holmes and Pollenz, 1997). Other experiments have also indicated the presence of an
additional 37-43 kDa protein associated with this complex (Chen and Perdew, 1994), and
also, a 330 amino acid protein with sequence similarity to a 52 kDa immunophilin coactivator of the glucocorticoid receptor, has been shown to be associated with ligand
activated AHR (Carver and Bradfield, 1997; Ma and Whitlock, 1997). Upon exposure to
ligand, AHR complex is translocated to the nucleus where the AHR can dimerize with
ARNT and induce gene expression by binding to the XRE or be transported back out into
the cytoplasm where it is degraded.
AHR is targeted for translocation to the nucleus by a nuclear localization signal
(NLS). The minimal NLS sequence for AHR has been identified as sequence of 27 amino
acid residues, numbering 13-39 in the protein sequence (Ikuta et ai., 1998).

This 27

residue sequence is described as a bipartite NLS with basic amino acid residues clustered
at both the 5' and 3' ends of the signal (see Figure 5). In vitro experiments with fusion
proteins containing the AHR NLS have shown that mutations in anyone of the residues
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AHR NLS Sequence Comparison
RKRRKPVQKTVKPIPAEGIKSNPSKRH

WT

QKRRKPVQKTVKPIPAEGIKSNPSKRH

NLS-l

QPRRKPVQKTVKPIPAEGIKSNPSKRH - NLS-2
Figure 20: Nuclear Localization Signal Sequence Comparison of wtAHR and NLS
Mutants: The AHR NLS is a bipartate NLS signal consisting of two regions rich in basic
residues separated by a spacer sequence. The basic regions of the NLS are shown in red
and the three red underlined bases at the N-tenninal end of the sequence are required for
the sequence to retain any ability to target the protein to the nucleus. The residues
shown in green are the mutated residues of the two mutants. The basic region involved in
DNA binding is underlined in black.
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13-15 is sufficient to completely knock out the ability of this sequence to target proteins
to the nucleus (Ikuta et al., 1998).
Although experiments with the previously described AHR NES mutants had
shown that blocking nuclear export of AHR also inhibits its degradation, it was still not
known if both nuclear import and export were necessary for degradation to occur.
Although degradation had been shown to occur in the cytoplasm it was not yet known if
agonist exposure and localization of AHR to the cytoplasm was sufficient to target AHR
for degradation. There remained the possibility that an event occurring in the nucleus
after import was necessary to make AHR competent for degradation. Vectors expressing
AHR proteins with mutated NLSs were constructed to test this hypothesis.
Qwikchange™ site-directed mutagenesis was used to generate the vectors encoding AHR
proteins with mutated NLSs.
As was necessary when generating the NES mutants, multiple functions of parts
of the NLS sequence had to be considered when deciding which residues could be mutated
without affecting the functionality of the protein in ways other than nuclear localization.
The basic region consists of residues 27-39 and is therefore completely overlapped by the
NLS signal previously discussed (Burbach et al., 1992; Fukunaga et al., 1995).

This

region is responsible for the DNA-binding ability of the AHR (Fukunaga et al., 1995) and
mutations made in this region could block the ability of AHR to bind the XRE and induce
gene expression. This possibility should have no bearing on the initial experiment to
determine if degradation is inhibited if the AHR is not transported to the nucleus, because
the NLS mutants are designed not to be transported into the nucleus and therefore cannot

102

dimerize with ARNT or bind to the XRE. However, additional experiments such as
microinjection of the NLS mutant proteins as controls would require a completely
functional protein except for the ability to be imported to the nucleus. Fortunately, the
previously discussed mutations in residues 13-15, which had previously been shown to
completely block nuclear localization of a fusion protein were outside of the DNA
binding region of AHR. However, in those experiments the NLS sequences were part of a
fusion protein and therefore, were never examined for the ability to bind DNA.
Based on this information two AHR mutants with defective NLSs were generated.
One mutant contained the single residue change mutation, RI3Q, and the other contained
two residue changes, RI3Q:KI4P. The single and double NLS mutations were designated
AHRNLS1 and AHRNLS2 respectively. Although a single mutation in bases 13-15 had been
shown to completely knock out nuclear localization in a fusion protein, the double
mutation was made to give added assurance that the NLS was disrupted for experiments
with the full length AHR protein.
2. Characterization of the NLS Mutants
Functionality of the two NLS mutants was then compared with that of wtAHR.
AHRNLS1 , AHRNLS2 , and wtAHR proteins were expressed in vitro and quantified by
Western blotting. Equal amounts of each AHR were then mixed with equal amounts of
ARNT protein and the sample was incubated in the presence of TCDD or DMSO for 2
hours at 30°C. After incubation a [32 p]dCTP labeled double stranded XRE probe was
added to each mix and then the new mixtures were incubated for an additional 15 minutes.
The fonnation of AHRIARNT complexes was then evaluated by EMSA (Figure 7). Both
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EMSA of AHR NLS Mutants
AHR

NLS-1

AHR

NLS-1

NLS-2

+

+

+

NLS-2 TCDD TCDD

TCDD

Figure 21:EMSA of AHR NLS Mutants: The functionality of AHR NLS mutants was
compared to that of wtAHR by EMSA. Both NLS mutants retained the ability to form
dimers with ARNT and bind to DNA in vitro.
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AHR/GFP Fusion Proteins
I

wtAHR
A70

I

I

A67

.

M67A70

L\NES
Figure 22: AHRlGFP Fusion Proteins: Efforts to generate AHRlGFP fusion proteins
were began with wtAHR and the four NES mutants. The fusion proteins were to be used
to observe the movement and degradation of AHR in real time rather than by means of
western blots and stained cells. To this time efforts to generate the fusion proteins have
been unsuccessful.
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transfected genes even if both are visualized by the AHR antibodies. Additionally the
presence of GFP would allow visualization with antibodies to the GFP protein so the
only protein visualized would be the transformant. Potentially the greatest benefit of this
approach would be the ability to follow in real time the import, export and degradation of
the AHRlGFP fusion. This would be possible because the GFP can be visualized under a
microscope without fixing and killing the cells. The NES mutants and wtAHR were to be
made first and if successful the same approach could be used with other AHR proteins
(Figure 8).
A three-part procedure was required to generate the AHRlGFP fusion proteins.
First the stop codon for the AHR gene would be replaced by a restriction site which
could be cut to open or linearize the plasmid and allow the insertion of the OFP sequence.
QwikchangeTM mutagenesis was used to replace the stop codon with the BssH II
restriction site.

BssH II was chosen because this procedure requires a single cut

restriction site and because the OFP sequence and the pSport plasmid already contained
sites for many of the readily available restriction enzymes. Plasmids containing a BssH II
site and each of the AHR proteins except AHRA69 were generated using this method.
Numerous attempts have been made to make a plasmid with AHRA69 and the BssH II site
but as yet none were successful. Second the GFP sequence was amplified from the
plasmid pEYFP-Nuc by polymerase chain reaction (peR). Primers were used which
generated a peR product with BssH II sites at both ends of the OFP sequence. Finally
both the pSportAHR vectors and the OFP peR product were digested with BssH II and
then ligated with T4 ligase. XLI-Blue supercompetent cells were transformed with the
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ligase mix then plated for overnight growth.

This third and final step necessary to

generate plasmids expressing AHRlGFP fusion proteins has been attempted a number of
times but as yet none have been successful. This project is unfinished at this time.

DISCUSSION
The work presented in this thesis was performed to set the stage for molecular
analysis of both the NLS and NES of the AHR protein, and as yet does not tell a
complete story. The production of the NES and NLS vectors were to form a basis from
which future research could be carried out on the AHR pathway. Indeed, these vectors
have already been used to address some of the important questions. The NES vectors
described within this thesis were used to show that blocking nuclear export of AHR
inhibits the degradation of the AHR protein (Davarinos and Pollenz, 1999; Pollenz and
Barbour, 2000). These results demonstrate that the export of the AHR is required for
degradation of AHR, thus answering the initial question posed for this work (Pollenz and
Barbour, 2000).
Since the export of AHR from the nucleus results in degradation of the AHR and
therefore greatly reduced levels of total AHR protein in the cell, it is likely that export
and degradation are important steps in regulating AHR mediated gene induction.
Degradation of the AHR protein is likely a mechanism to terminate or reduce the
induction signal and attenuate the cellular response to the stimulant.

In recent

experiments, the effects of blocking the export of AHR on gene induction have been
examined. Results of these experiments indicate that gene induction is increased when
AHR export and subsequent degradation is inhibited (Pollenz and Barbour, 2000).
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To this point experiment with cells expressing the AHR NES mutant proteins
have been conducted in transiently transfected cells. Transient transfections result in
uneven expression of the genes being studied in the individual cells, with some cells highly
overexpressing and others with little or no expression.

This uneven expression can

produce results that are inconsistent and therefore difficult to understand.

Stable cell

lines are currently being generated which express these plasmids and it is expected that
results of studies using these cells will allow more rigorous analysis of export and AHR
signaling.
Recent experiments with the NLS mutants described here have suggested that
translocation of AHR to the nucleus may play some role in targeting the protein for
subsequent degradation (Pollenz, unpublished data). In these experiments AHR proteins
with the mutant NLS sequences described in this thesis have been shown to be localized
to the cytoplasm even after exposure to TCDD. Evidence from western blots of lysates
from cells expressing AHR with mutant NLS sequences have also indicated that
degradation of the import defective AHR proteins occurs at a slower rate than does that
of wtAHR. These experiments have also been conducted in transiently transfected cells
and for future experiments stable cell lines are being generated.
Other future plan include the eventual creation of "knock-in" mIce expressIng
AHR genes with both deficient NES and NLS sequences.

The availability of these

mutations in mice will allow the examination of differences in phenotypes, if any, of mice
with the different import and export signals. Of particular interest will be the effects of
potentiation expression of genes induced by the AHR pathway, which is expected to

111

occur in these animals, since they will lack the ability to rapidly export and degrade AHR,
thus attenuating the response to agonist.

These changes in phenotype should yield

valuable information concerning the role AHR localization in the growth and development
of the transfected animals.
Although efforts to generate plasmids which express AHRlGFP fusion proteins
were unsuccessful, this work will continue. If this project is successfully implemented it
should be possible to observe in real time the import, export, and degradation of AHR,
and therefore obtain much more detailed and accurate information about the AHR
mediated pathway.
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